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 Two experiments evaluated the effects of delayed, long-acting coated implants or 
uncoated implants to non-implanted heifers fed for constant or varying days on feed. In 
Exp. 1, heifers were implanted with either Revalor-XH on d 1, Revalor-200 on d 1, 
Revalor-XR on d 1, or Revalor-200 on d 70 compared to non-implanted control heifers 
when fed for an average of 198 d. In Exp. 2, heifers were implanted with Revalor-200 on 
d 1 and reimplanted with Revalor-200 on d 100, Revalor-XH on d 1, or not implanted and 
fed for different days on feed: 151, 165, 179, or 193. Implanting heifers increased BW, 
ADG, G:F and HCW compared to non-implanted heifers with no differences between 
implant strategies. As heifers were fed for longer DOF, ADG and G:F decreased. 
Implanting and increasing DOF substantially increased BW and HCW but increasing 
initial implant dosage did not result in a performance advantage when heifers were fed 
for varying DOF. 
 Two experiments evaluated the effect of timing of administering a terminal 
implant in heifers and steers when fed for 180 days. In Exp. 3, heifers were implanted 
with Revalor-IH and reimplanted with Revalor-200 at 20, 60, 100 or 140 DOF. In Exp. 4, 
steers were implanted with Revalor-IS and reimplanted with Revalor-200 on 20, 60, 80, 
 
 
100 or 140 DOF. In Exp. 3, final BW, ADG, G:F, HCW and LM area responded 
quadratically and were maximized between 88 and 103 on terminal (DOT) implant. In 
Exp. 4, carcass-adjusted final BW, ADG, G:F and HCW responded quadratically and was 
optimized between 87 and 104 DOT. Therefore, the optimal duration for a terminal 
implant appears to be between 80 and 120 DOT, with an average of 96 DOT for both 
heifers and steers.  
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Introduction 
 Profitability in the cattle feeding industry is driven by weight gain and efficiency 
in the feedlot. The feeding industry is constantly evolving and adapting innovative 
technologies to achieve more profit efficiently.  
 Steroidal combination implants have been extensively used and studied for over 
50 years. Implants have consistently been shown to increase gain and hot carcass weight 
by increasing frame size and delaying fattening (Reinhardt, 2007; Smith et al., 2018). 
However, due to this effect, cattle must be fed for longer days on feed (DOF) to achieve 
similar fatness to non-implanted cattle. Traditionally, the payout of most uncoated 
implants is approximately 60 to 120 days (Mader, 1998). More recently, cattle producers 
have been feeding cattle for longer DOF which causes logistical issues for reimplanting.  
The FDA has approved the use of coated implants, which delays the release of the partial 
or entire dose of the steroidal hormones until approximately 70 to 80 d after implanting. 
These long-lasting implants may remove the need to reimplant, potentially reducing the 
cost and logistical issues sometimes associated with reimplanting. 
 The ideal time to administer the terminal implant following an initial implant has 
recently been of interest. Duckett and Pratt (2014) demonstrated that both steers and 
heifers given an initial implant and reimplanted with a combination terminal implant had 
a 20% increase in ADG and 13.5% increase in G:F compared to non-implanted cattle. 
However, the data describing the optimal time to administer a terminal implant are 
limited, and most recommendations come from anecdotal evidence or consultant’s 
individual experiences.  
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 Therefore, the objectives of this study were: to evaluate the effects of coated long-
acting, delayed release implants in heifers fed for constant DOF or the effect of 
traditional, aggressive implant strategies compared to long lasting implants when heifers 
are fed varying DOF (Exp. 1 and 2) and evaluate and define the optimal time to reimplant 
heifers and steers following a mild initial implant (Exp. 3 and 4).   
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CHAPTER I. Review of Literature 
Overview of Implants 
 
Growth Promoting Anabolic Steroids 
Anabolic steroids are a group of natural or synthetic estrogens (female hormone) 
or androgens (male hormone) approved for use in beef cattle for growth promoting 
purposes (Meyer, 2001). Since the 1950s, many steroid hormone drugs have been 
approved for use in beef and sheep production, including estrogen, progesterone, 
testosterone, and synthetic versions of all compounds (FDA, 2017). These compounds 
have been shown to improve growth rate, feed efficiency and protein deposition in 
experimental or commercial use (Montgomery et al., 2001). According to the USDA 
National Animal Health Monitoring System survey of feedlots in 12 major cattle feeding 
states with over 1,000-head capacity, 97% of all cattle entering the feedlot at greater than 
318 kg were implanted at least one time. Of that 97%, 30% were implanted twice. 
Furthermore, 60% of the cattle implanted once received an androgenic compound and of 
the cattle implanted twice, 78% received an androgenic compound (Duckett and Andrae, 
2001; Johnson and Beckett, 2014).  
Implants are approved for most segments of beef production, including suckling, 
grazing, and finishing steers and heifers (Duckett and Andrae, 2001) and if used properly, 
can have a substantial return on investment (Hutcheson, 1993). While the return on 
investment varies, it is estimated to be greater than $5 per $1 spent (ZoBell, et al., 2000).  
There are several diverse types of single and combination ingredients used in 
implants, including Estradiol-17β (E17), zeranol, trenbolone acetate (TBA), and 
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progesterone. However, most implants are comprised of estrogens, androgens, progestins, 
which are all naturally-occurring in all animals, regardless of gender (Johnson and 
Beckett, 2014). These compounds, or the combination of two, account for all 
commercially available implants (Botts, 1997). It is estimated that nearly two-thirds of all 
marketed implants in the United States are a combination of TBA/E17 (Johnson and 
Beckett, 2014), and therefore will be the focus for this review. Implants are approved to 
be administered subcutaneously in the middle third of the back of the ear, which allows 
for a slow, consistent steroid release into the blood stream to be administered to body 
tissues, without the implant site (ear tissue) entering the human food supply (Johnson and 
Beckett, 2014).  
Mode of Action 
 Steroidal hormones elicit a response by working through the endocrine and 
paracrine systems and their hormones to regulate growth and protein metabolism (Meyer, 
2001). In general, steroid implants act primarily by binding to cytosolic receptors, which 
then act on the nucleus to promote gene expression and translation of growth-promoting 
hormones such as IGF-1 and growth hormone (Bryant et al., 2010).  It is widely accepted 
that cattle implanted with a combination of TBA and E17 experience a synergistic effect 
and show an increase in performance compared to cattle implanted with TBA or E17 
alone (Pampusch et al., 2008; Reinhardt, 2007). However, it is important to evaluate 
these compounds individually first to fully understand how they work effectively 
together.  
 Estradiol-17β has a greater anabolic effect compared to androgens in cattle and 
sheep and growth related to E17 seems to be dose-dependent (Meyer, 2001). Meyer 
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(2001) proposed possible indirect and direct effects of E17. The author discussed that 
E17 stimulates and increases estrogen receptors on the skeletal muscle cells, which in 
turn, increases stimulation of muscle mRNA to increase protein anabolism and mineral 
retention. Estradiol-17β acts indirectly on the hypothalamus to secrete more growth-
hormone releasing hormone or directly by stimulating the pituitary gland to secrete more 
growth hormone, and therefore increase growth hormone receptors in the liver, and 
release more insulin-like growth factor 1 (IGF1) into the blood stream (Trenkle, 1997; 
Meyer, 2001). Increased levels of IGF-1 and IGF-1 mRNA have a positive effect on 
increasing protein accretion of existing muscle fibers and promoting hypertrophy of 
skeletal muscle (Kamanga-Sollo et al., 2008; Johnson and Beckett, 2014). However, to 
sustain long-lasting hypertrophy since the number of muscle fibers is essentially fixed at 
birth, there needs to be proliferation of new cells through stimulation of inactive satellite 
cells by IGF-1 (Johnson and Chung, 2007; Kamanga-Sollo et al., 2008).  
 Trenbolone belongs to a group of the most efficient anabolic steroids, likely due 
to its multiple hormonal activity (Meyer, 2001). While the exact mechanism of 
trenbolone on growth and efficiency of cattle is not completely understood, it is believed 
that trenbolone acts like other androgens, and exhibits strong binding to the androgen 
receptor, progestin receptor, and glucocorticoid receptor (Meyer, 2001). Meyer (2001) 
also proposed that trenbolone suppresses tyrosine amino transferase and consequently 
prevents amino acid catabolism when compared to testosterone or other androgens. 
Furthermore, the author concludes that trenbolone acts as an anti-glucocorticoid by 
binding to the glucocorticoid receptor and further prevents catabolic activity.  While it is 
thought that TBA has very limited stimulatory effect on muscle IGF-1, it is believed that 
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TBA is the most efficient at acting directly on the muscle cells through several pathways 
to promote proliferation of bovine satellite cell cultures (Pampusch et al., 2008; Johnson 
and Beckett, 2014). However, as previously mentioned, the combination of E17 and TBA 
have a greater response than when E17 or TBA are used independently (Hayden et al., 
1992; Dayton and White, 2008; Pampusch et al., 2008; Johnson and Beckett, 2014). It is 
believed that E17 stimulates muscle protein deposition and TBA works to enhance this 
effect, and because of the increase of muscle protein deposition, it is the increase in 
muscle synthesis and not the decrease of muscle protein degradation that causes the 
responses observed from the use of combination implants. However, the exact 
mechanism of how these two hormones work on other growth promoting hormones and 
their receptors and tissues is not fully understood and warrant further research (Hayden et 
al., 1992; Pampusch, et al., 2008).  
 Using a combination implant of TBA/E17 promotes an increase in muscle 
hypertrophy and protein synthesis in the first 40 days after implantation compared to non-
implanted cattle (Johnson and Chung, 2007; Chung et al., 2012). To support increased 
muscle hypertrophy and protein synthesis, quiescent cells, which contribute to the growth 
plateau observed in control cattle, must be activated, increase DNA, and then be acted 
upon by growth factors, such as IGF-1, to further promote cell growth and proliferation 
(Johnson and Chung, 2007; Dayton and White, 2008; Chung et al., 2012). Combination 
implants lead to an increase in IGF-1 and IGF-1 mRNA in longissimus muscle, which 
can support an increase in muscle hypertrophy (Johnson and Chung, 2007). Additionally, 
TBA/E17 has been shown to increase the rate in which cell proliferation occurs in vitro 
(Dayton and White, 2008).  
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Release Rate and Factors that Influence 
 There are two distinct styles of manufacturing of implants: compressed pellets 
and silastic rubber. Generally, silastic rubber is used with estradiol implants, whereas 
compressed pellets can be used with TBA, E17, or combination implants. Because 
compressed pellets are the most common implant type, they will be the focus of this 
review. These types of pellets are generally a mix between the active ingredient and a 
carrier, such as lactose, cholesterol, or a large polymer of polyethylene glycol ( Preston, 
1999; Cady et al., 2002). The use of lactose or cholesterol allows the compressed pellets 
to dissolve completely overtime at rates dependent on several factors, such as type of 
carrier used and pressure utilized to form the compressed pellet (Istasse et al., 1988; 
Jennings, 2012). Targeted release rate to the animal is between 0.75 mg/day/animal to 1.2 
mg/day/animal, which is desired to attain the performance response for the period that the 
animal is in the feedlot (Cady, 2002).  
 Compressed implants were first used when diethylstilbestrol (DES) was approved 
for implanting instead of oral dose in 1955 (Raun and Preston, 2002). As previously 
mentioned, compressed implants can be made with a variety of carriers, with lactose and 
cholesterol being the most common. Lactose makes hard pellets that are well absorbed, 
and is generally used in short-term implants, as lactose degrades over a 60 to 80-day 
period. Cholesterol, on the other hand, dissolves and releases active ingredients at a much 
slower rate, making it ideal for long-term implants (Bartle et al., 1992). Additionally, 
compressed pellets can include an antibiotic pellet, which prevents infection at implant 
site (Stevens et al., 1999). While cholesterol is generally utilized in long-acting implants, 
Preston (1999) found that a response was sustained for 84 but not 126 days. Because of 
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this, some implants are encapsulated in a polymer or osmotic membrane to modulate the 
release rate (Preston, 1999). The pellets are generally 3 mm to 6 mm in length, with 4 to 
5 mm being preferred. The pellet diameter varies from 2 mm to 4 mm, with a preferred 
diameter of 2.5 to 3.5 mm. These pellets may also have a beveled edge (Cady, 2002).  
 The pressure used to form compressed implants is vital to the rate of release of the 
active ingredient and ultimately, the payout of the implant; however, most levels of 
pressure are confidential and not reported in the literature (Preston, 1999). The pressure is 
measured in kiloponds (kp) and Revalor implants are compressed at 7.14 kp, and while 
the exact value of force utilized to compress Synovex and Component is unknown, it is 
presumably similar (Cady, 2002; Jennings, 2012). In general, the more compressed a 
pellet is, the slower degradation rate and the slower release of the active ingredient.   
Payout of Hormones after Implanting 
 The first most extensive look at hormonal payout of implants was observed with 
implanting at various times with DES. Implants from different lots and manufacturers 
were evaluated and it was found that the implants had different half-lives and percentages 
remaining after 60 days, regardless of the manufacturer claim, all exhibiting first-order 
release patterns (Preston, 1999). Similar release patterns were observed with E17 + 
progesterone implants. These results and the first-order kinetics demonstrate that there is 
a greater release of implant hormone during the first 60 days post implantation, with 
measurable implant hormone being observed up to 120 days post-implantation (Preston, 
1999).  
 While the concentration of hormones, namely TBA and E17, in blood, plasma, and 
serum can provide useful information, it is noted there are limitations in their meaning due 
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to considerable variation (Preston, 1999). Release of active ingredients in hormones are 
generally biphasic, which results in an initial peak in concentration of circulating hormones 
1 to 3 d after implanting, followed by a decline in concentration following first order 
kinetics (Brandt, 1997; Preston, 1999). A threshold concentration is also considered where 
there is no further animal response expected. The threshold concentration for E17 is 
thought to be between 3 and 5 pg/ml, while the threshold level of TBA has been difficult 
to define and is still unclear because there are still elevated levels remaining after 120 days 
(Preston, 1999). When heifers were implanted with TBA alone or in a combination implant, 
peak serum TBA levels were observed 1 day after implantation, decreased over time, and 
showed a minor peak around day 56 and further decreased through day 140. However, in 
the same study, E17 levels were elevated 1 day after implanting, but did not peak until 56 
days after implanting. Comparable results were shown in steers (Preston, 1999).  
Serum Urea-Nitrogen 
 Steroidal implants work as a repartitioning agent and work to increase the amount 
of protein deposition and retention in the animal compared to fat (Bryant et al., 2010). 
The increase in protein retention, and ultimately muscularity, can be observed in a 
decrease of serum urea-nitrogen. The lower serum urea nitrogen levels indicate 
alterations in nitrogen metabolism and protein turnover in implanted heifers. These 
changes can also be attributed to an increased requirement for amino acids (Galbraith, 
1980). Heitzman and Chan (1974) found that heifers implanted with 300 mg of TBA 
showed decreased plasma urea-nitrogen 14 days post-implantation and remained lower 
than non-implanted heifers until 49 days post-implantation. In similar studies, plasma 
urea nitrogen was decreased, but total plasma protein was not affected when cattle were 
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fed a 12% CP diet (Jennings, 2012).  Further, Parr and others (2014) found that when 
steers where implanted with either Revalor-S or Revalor-XS, serum urea-N 
concentrations increased over time, but implanted cattle had lower levels of serum urea-N 
compared to non-implanted steers.  
Non-Esterified Free Fatty Acids 
 In general, implanting does not alter NEFA concentrations in finishing cattle 
(Galbraith, 1980; Parr, et al., 2011).  Enright and others (1990) evaluated the effect of 
subcutaneous growth promoting injections (growth hormone and/or estradiol) on 63 
Friesian steers and found that there was no effect on NEFA levels in cattle that received 
any growth hormone or estradiol treatment. Similarly, when Parr et al. (2014) evaluated 
the effects of no implant, Revalor-S or Revalor-XS on blood metabolites of steers 
(n=168), they found that NEFA levels were not affected by implant treatment, but 
increased over time, independent of implant treatment.  
Live Animal Performance Response to Implants 
 Live animal performance in response to implant treatments has been shown to be 
altered significantly. Duckett et al. (1997) summarized 77 research trials that utilized 
single or multiple implants across both steers and heifers and evaluated the effect on live 
performance. The authors found that both steers and heifers implanted with a 
combination of TBA/E17 performed significantly better than animals that received either 
an estrogen or androgen implant alone. Furthermore, implanting with a combination 
implant increased ADG by 8 to 20%, DMI by 7% and improved feed efficiency by 5 to 
10% depending on heifers or steers. Animals that were given an estrogen only implant 
showed a 9-14% improvement in gain, 4% increase in DMI, and a 4-5% improvement in 
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efficiency. Steers that received an androgen only implant showed a 16% increase in gain, 
but there were no other performance responses observed.  
 Bartle and others (1992) evaluated the effect of TBA/E17 combination implants 
and the optimum combination for steer performance. Combination implant treatments 
included a 5:1 ratio of TBA/E17 and consisted of 20 mg TBA/4 mg E17, 80 mg TBA/16 
mg E17, or 140 mg TBA/28 mg E17. Additionally, there was a non-implanted control 
treatment, and steers that received either 140 mg TBA alone or 30 mg of E17 alone. The 
authors found that there was a linear increase in ADG among the combination implants 
and ADG was increased 18% over the control. Feed efficiency also improved linearly 
with higher dose implants. Steers that were implanted with only E17 showed a 7% 
increase in ADG and a tendency to improve feed efficiency. The authors recognized that 
these values were slightly lower than other values previously reported but contributed 
that to the longer duration of this feeding study (168 days) and the potency of E17 
implants in longer day feeding trials. Trenbolone acetate implants alone had no effect on 
performance characteristics over the control. Therefore, the author concluded that a 
combination implant of 140 mg TBA/28 mg E17 resulted in the greatest performance 
advantage compared to non-implanted or single E17 implanted cattle. 
 Guiroy and others (2002) summarized 13 implant trials that utilized 15 different 
implant strategies, including a combination of non-implanted control, single implants, 
and combinations of implants in both heifers and steers. The authors concluded that there 
was an improvement in ADG and feed efficiency in both steers and heifers treated with 
an implant strategy compared to non-implanted cattle. Furthermore, this summary further 
confirmed previous work that anabolic implants increase the mature body size of steers. 
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Bryant et al. (2010) compared 2 different implant strategies in both steers and heifers 
compared to non-implanted controls. In steers, steers implanted with Revalor-IS and 
reimplanted with Revalor-S had 10% greater final BW, 19% improvement in ADG, 12% 
increase in G:F and 9% greater DMI compared to non-implanted steers. Heifers that 
received Revalor-200 at trial initiation and fed for 120 d had an 4.4% increase in final 
BW and 14% greater ADG compared to non-implanted heifers.  
 Duckett and Pratt (2014) analyzed the implant response of over 30 implant trials 
updated since 1997 and found that implanting with estrogenic implants or combination 
implants resulted in a 16 to 20% increase in ADG and a 9 to 14% improvement in feed 
efficiency in steers compared to a nonimplanted control. Furthermore, Duckett and Pratt 
evaluated the economic impact of using anabolic implants and the added performance. 
The authors found that using modern prices, a combination implant would increase 
returns by $163/head and if two combination implants were used, there would be an 
estimated return of $218.58/head over non-implanted cattle. Therefore, the use of 
anabolic implants for growth and performance purposes has become a regular practice 
among feed yards to improve performance and cost of gains.  
 In general, anabolic implants, and more specifically, combination implants, have 
been shown to improve ADG and feed efficiency when compared to non-implanted cattle 
in both steers and heifers. With the increased ADG and efficiency, profitability from 
implanted cattle has increased. Furthermore, implanted cattle have increased mature body 
size, which potentially translates into more saleable weight, further increasing 
profitability.  
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Carcass Response to Implants 
 Duckett and Pratt (2014) summarized the effect of anabolic implants on carcass 
characteristics of steers utilizing the same study as previously outlined. The authors 
reported that a single estrogenic implant increased HCW by 3% over non-implanted 
steers, but a single combination implant or reimplanting later in the finishing phase 
resulted in a 6 to 7.5% increase in HCW over a negative control. Bryant et al. (2010) 
found that steers implanted twice in the finishing phase (Revalor-IS followed by Reavlor-
S) had 11% greater HCW when compared to non-implanted steers. When steers were 
implanted once during the finishing phase, LM area was increased by 5.8% and if 
implanted twice, LM area increased 9% over non-implanted cattle. Furthermore, there 
were no reported changes in fat thickness related to implant strategies, thus the increase 
in LM area was directly related to the increase of HCW, so only a minor change in yield 
grade was attributed to implanting (Duckett and Pratt, 2014).   
Duckett and Pratt (2014) also reported that skeletal maturity increased with the 
use of anabolic implants. When estrogenic implants were used, skeletal maturity was 
advanced by 20 to 24% in steers. A linear increase in maturity with the number of 
combination implants used in the finishing phase was also reported. However, if an 
implant was given later in the finishing phase (for example, around day 60), there was no 
difference in maturity score compared to non-implanted steers, but cattle implanted on 
day 0 showed increased maturity scores of 11 to 16 points.  
Duckett and Pratt (2014) observed a decrease in marbling scores when either 
estrogenic or combination implants were utilized. When a single estrogenic implant was 
used, marbling score was decreased by 3.75%, whereas with the use of a combination or 
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multiple implant strategy, marbling score was reduced by 7.5 to 11.5% compared to non-
implanted cattle. Furthermore, the authors correlated the decrease in marbling score to the 
increase in LM area observed with implanted cattle and found that there is a negative 
relationship between the two variables. This means that as LM area increases due to 
implant strategy, marbling score is reduced because of a dilution effect when cattle are 
fed to similar DOF. Johnson et al. (2013) found that when cattle were fed on a time 
constant-basis, implanted cattle had a 7% reduction in fat cover, implying that although 
cattle gain faster than non-implanted cattle, they do not accumulate fat at a proportional 
rate for the increase in growth observed with implanting. However, many research trials 
comparing implant strategies have shown minimal differences in fat thickness due to 
implanting (Duckett and Pratt, 2014).  
Johnson et al. (1996) utilized 64 crossbred steers in a serial slaughter experiment 
to observe the effects of a combination implant on live performance, carcass 
characteristics, and fat deposition compared to non-implanted control cattle. Cattle were 
implanted with Revalor-S (Merck Animal Health) or given no implant and were 
harvested on one of 4 days consisting of days 0, 40, 115 or 143. The dates were chosen to 
provide an initial carcass composition (d 0), day of maximum response to the implant (d 
40), the manufacturer’s recommended date of harvest (d 115) and when circulating 
hormones were projected to return to baseline levels (d 143). Overall, there were no 
reported differences in HCW (353 kg vs 332 kg, respectively) or fat thickness (0.84 cm 
vs 0.77 cm, respectively) between implanted and control cattle, although these numbers 
were numerically increased.  Between d 40 and 115, implanted cattle had greater LM area 
compared to non-implanted cattle, but this advantage was not maintained at 143 days. 
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Furthermore, there were no significant effects on marbling score between d 40 and 115, 
but implanted cattle had a lower numerical marbling score compared to control cattle at 
143 days. Because of no observed effect on HCW, LM area, or fat deposition, there were 
no differences in calculated yield grade among treatments. The lack of differences could 
be due to the small number of cattle utilized or because of loss of potency of implants 
later in the feeding phase (Johnson, 2013).  
In a review by Montgomery et al. (2001), heifers that received an androgen 
implant or a combination implant during the finishing phase had heavier HCW and an 
increase in LM area compared to heifers that received only an estrogen-based implant or 
no implant. Reimplanting heifers also resulted in heavier HCW and further increase in 
LM area compared to non-implanted heifers. Additionally, Duckett et al. (1997) found 
that the use of a single implant in heifers doesn’t seem to improve yield grade, however, 
reimplanting (regardless of the implant combination) seems to improve yield grade, likely 
due to a decrease in fat thickness in relation to HCW. While there is still a performance 
increase from the use of implants in heifers, the magnitude in which heifers respond is 
lower compared to steers.  
Platter et al. (2003) found that in eleven implant strategies, including lifelong 
implanting, steers that received two or fewer implants produced carcasses with greater 
USDA marbling scores than cattle that received four or five implants in their lifetime and 
non-implanted negative controls had the greatest marbling score compared to all implant 
strategies. However, marbling score was not affected by implant strategies implemented 
prior to the finishing phase. Samber et al. (1996) reported that steers that were implanted 
three times in their lifetime had lower USDA marbling scores and carcasses grading 
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choice or prime compared to non-implanted cattle or cattle that were delay implanted by 
30 d and only given two lifetime implants. All studies discussed thus far have been 
conducted on an equal DOF basis. Nichols et al. (2002) reported that when cattle are 
finished to the same physiological endpoint, the percentage of protein, adipose, and bone 
is similar with implanted or non-implanted cattle, yet implanted cattle maintain an 
advantage in BW. This is due to implants causing an increase in the growth curve, which 
modifies the use of protein vs fat deposition and modification of nutrient supply. This is 
an important management strategy for feed yards to maintain performance advantages 
without sacrificing carcass merit.  
Implant Strategies and Ideal Reimplantation 
 As previously discussed, it is important for feed yards to consider and predict 
carcass composition, especially with the use of implants. The length of anabolic activity, 
which is commonly referred to as payout, is important to consider when designing an 
implant program and these programs should be designed to achieve predetermined 
performance and carcass goals (Brandt, 1997). Vasconcelos and Galyean (2007) surveyed 
29 consulting nutritionists representing all cattle feeding areas of the United States and 
respondents were responsible for approximately 69% of cattle on feed and provided their 
recommended days on terminal implant. Of the 29 consultants surveyed, 21 consultants 
recommended that the maximum days be 110 or 120 d or less. This is important to note 
because as cattle are being fed longer days on feed, the need for reimplanting and 
management increases in importance.  
 As previously discussed, active hormone components are generally delivered by 
dissolution of the carrier in the implant or by dissociation of the hormone from a rubber 
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carrier vehicle. The rate of release of the hormone from either method is the primary 
determinant of payout period, which is defined as the length of time that an implant can 
promote growth (Reinhardt, 2007). However, regardless of the payout period, an animal 
requires a threshold level of exogenous hormone for a growth response to be observed. 
With implanting, the highest level of delivered hormones are observed in the first 30 days 
after implanting, and as delivery slows, the hormone levels fall below the threshold level 
and growth enhancement seizes (Reinhardt, 2007). However, by reimplanting, feedyards 
can manage the minimum threshold and restart the release pattern, allowing the growth 
promoting benefits to continue with cattle fed longer DOF (Reinhardt, 2007). 
 Guiroy et al. (2002) studied the effect of particular implant strategies on their 
ability to change final BW when animals are adjusted to same final body composition 
leading to the ability for feeders to be able to choose the implant strategy that is the most 
appropriate for different classes of animal and in turn, maximize profitability and meat 
quality.  The authors concluded that anabolic implants increase mature body size of cattle 
and that implanted steers should be harvested at 39.5 kg heavier final BW and implanted 
heifers at 16.8 kg heavier final BW compared to non-implanted controls to achieve 
similar marbling scores. The decrease in physiological age is what causes the decrease in 
marbling score when animals are fed to similar DOF because the implanted animals are at 
a leaner stage of growth compared to non-implanted cattle (Reinhardt, 2007).  Therefore, 
animals who receive a more aggressive implant or multiple implants will require more 
DOF to reach the same empty body fat percentage and equal carcass composition (Guiroy 
et al., 2002).  
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 Mader (1997) determined that implant strategies should match implant dosage or 
potency to the animal’s age, weight, and production goals to maintain blood hormone 
levels in an optimum response range. Implant strategies can be tailored to fit the 
individual feeder’s animal type and marketing opportunities by altering the dose of 
hormone administered or the frequency of implanting. This could be of particular 
importance when feeding large-framed continental breeds, which would likely require 
less hormone to achieve desired carcass growth, whereas a British-influenced breed may 
tolerate more aggressive implant strategies to encourage lean muscle deposition, without 
sacrificing their inherent ability to deposit intramuscular fat (Johnson et al., 2013). 
Ultimately, to gain optimum growth benefits of the implant, it is necessary to leave the 
implant in the animal throughout the entire payout period, which is generally 50 to 200 
days, depending on the implant (Johnson et al., 2013).  
 Other implant strategies have evaluated the effect of various initial implant doses 
followed by a common terminal implant on growth performance and carcass 
characteristics. Hilscher et al. (2016) evaluated three different initial implant strategies in 
heifers that included: 80 mg TBA + 8 mg E2 (Revalor-IH, Merck Animal Health), 140 
mg TBA + 14 mg E2 (Revalor-H, Merck Animal Health), and 200 mg TBA + 20 mg E2 
(Revalor-200, Merck Animal Health), followed by 200 mg TBA + 20 mg E2 (Revalor-
200) 89 d later. The authors found no differences in final BW, DMI, ADG, G:F, or HCW 
regardless of initial implant strategy. The author reported a tendency for a lower 
calculated YG for more aggressive initial implants and a decrease in marbling score as 
initial implant dose was increased. Oney et al. (2018) observed similar results in steers 
when initial implant strategies were compared. There were no differences reported in 
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feedlot performance or carcass performance. However, when the author analyzed interim 
performance, the cattle that were more aggressively implant initially gained faster and 
more efficiently early in the feeding period but lost the advantage as the feeding period 
progressed. These data from Hilscher et al. (2016) and Oney et al. (2018) suggest that 
aggressive initial implants have minimal impact on growth or carcass performance, 
however, mild initial implants may be less detrimental on quality grade when cattle are 
fed for the same number of days.  
 Steroidal implants are an effective non-nutritional management tool that feeders 
and producers can utilize to increase the performance and economic efficiency of beef 
cattle (Nichols et al., 2002).  However, because of alterations in physiology of beef cattle 
when implants are used, it’s important to feed cattle longer DOF or to a similar 
compositional end point to avoid negative effects on carcass merit and marbling scores 
(Johnson et al., 2013).  
Predicting Carcass Composition 
Serial Harvest 
 Serial harvest experiments have been vital in determining and understanding 
carcass composition of beef cattle. The use of serial harvest has allowed researchers to 
understand how cattle grow and accrue protein and fat as the animal matures from birth of 
harvest. This information can then be used to predict the most effective nutritional and 
marketing strategies for certain classes of cattle. Haecker (1915) recorded one of the first 
serial harvest experiments that followed animals from approximately 1 week to 25 mo of 
age, harvesting a representative animal to analyze for body composition. The author 
utilized 260 steers and the representative animal was harvested at 45 kg and every 45 kg 
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period thereafter. The harvested animal was analyzed for chemical composition. The data 
show that there are minor variations and remarkable uniformity in the composition of steers 
in the designated growth periods with very limited variation in red meat of animals of the 
same breed and age. The most notable change in carcass composition occurs in fat 
deposition. There is a higher affinity for accruing protein from 45 kg to 318 kg, but after 
318 kg, animals begin depositing more fat rather than protein. However, this experiment 
was done using British breeds, which tend to finish and mature at a more rapid rate when 
compared to Continental breeds. Koch et al. (1976) studied the growth period of 14 
different breed combinations that included both British and Continental breeds. The steers 
that had Continental influence took more DOF to reach the same fatness as cattle of British 
influence, however, at the same end point, the Continental steers had more red meat and 
ultimately greater retail product. Steen and Kilpatrick (1995) supported these findings and 
they concluded that animals with Limousin and Belgian Blue influence had greater lean 
content in their carcasses with larger eye-muscles and a greater yield of saleable red meat, 
leading to a more profitable carcass. This was further solidified using the Germplasm 
Evaluation Program at the U.S. Meat Animal Research Center. Wheeler et al. (2005) 
concluded at constant BF thickness, carcass from British-influenced steers were lighter 
than Continental-influenced, and British influenced cattle were earlier maturing, requiring 
less DOF to reach a consistent 25% fat trim endpoint. Berg and Butterfield (1968) 
harvested four Hereford calves at birth and then every 6 months following until they were 
24 months of age and were able to identify that animals increase bone mass early in 
development, muscle intermediate, and fat late in development, or between 12 and 18 mo 
of age. Serial harvest studies like the ones previous outlined are vital to the development 
29 
 
of nutritional requirements for energy of maintenance and gain in beef cattle, which are 
useful to determining the change in carcass composition over the feeding period.  
 Bruns et al (2004) evaluated the changes in carcass composition over the course of 
an entire feeding period, rather than just focusing on animal performance at one-time 
period. Serial harvest groups were targeted so that their HCW would be approximately 204, 
250, 295, 340, and 386 kg. As DOF increased, live BW, HCW, dressing percent, LM area, 
fat thickness, yield grade, and marbling score all increased linearly. The authors also 
reported that as DOF increased, ADG decreased linearly. In a review by Streeter et al. 
(2012), ADG was decreased and feed efficiency was decreased in steers fed for additional 
days, but heifers decreased ADG at an increasing rate and increased feed efficiency when 
DOF were increased. However, Zinn et al (1970) found that ADG increased with increasing 
time on feed, but there were no significant differences in ADG after 120 DOF.  
 Vasconcelos et al. (2008) performed a feedlot trial utilizing 560 steers to evaluate 
the effect of varying days on feed on performance and carcass characteristics. Treatments 
included steers fed for 137 d to imitate under-finished cattle, 157 and 177 days to reach 
appropriate market condition, and 198 days to imitate over-finished cattle. Cattle were 
stratified by predicted DOF required to reach Choice grade and treatments were then 
assigned randomly within strata. Consistent with data previously discussed, final BW 
increased as DOF increased. Average daily gain and feed efficiency responded 
quadratically, which agrees with data previously reported from Van Koevering et al (2005). 
Relative to carcass characteristics, there was a linear increase in HCW, dressing percent, 
and 12th rib fat observed as DOF increased. Further, yield grade, marbling score, LM area, 
and kidney-pelvic-heart fat responded quadratically to increased DOF.  
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Streeter et al. (2012) pooled three large pen studies to evaluate the effect of days 
on feed (146, 167, or 188 d) on performance and carcass parameters and economic 
returns based on marketing strategy when feeding heifers.  Much like the previous data 
presented, the author found a quadratic increase in live final BW (final BW= -
0.0081*day2 +2.8061*day +1114.3) and a linear increase in HCW (HCW= 1.8554*day + 
708.7), dressing percent, and percent grading choice or better, but a 7% decrease in ADG 
and 8% decrease in feed efficiency.  
 While serial harvest experiments are usually difficult to appropriately conduct, 
they have been proven to be vital to understanding changes in growth patterns and in turn 
help with more accurate feeding and marketing programs.  
Value of Additional Days on Feed 
 Utilizing data from serial harvest trials and carcass composition models, feedlot 
managers can make more informed marketing decisions that are the best fit in individual 
operations. This information can help feed yard managers know when to market cattle for 
maximum profitability. Producers use various methods of pricing cattle at harvest. 
Marketing strategies for selling fed cattle include live BW basis, HCW basis, or carcass 
value grid basis. Depending on the marketing strategy decided upon by the feed yard 
manager, some have reduced the number of days on feed striving for premiums for yield-
driven grids or have kept cattle on feed for additional days on feed to achieve premiums 
for higher grading cattle (Feuz, 2002). Hicks et al. (1987) found that cattle that were fed 
for longer days on feed had heavier HCW and in turn, returned more profit because of 
extra pounds sold. However, the author cautions that an increase in time led to a decrease 
in live performance, and therefore, if marketed in a different scenario, could be less 
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economically favorable due to increased feed costs and potential for overweight 
carcasses.   
 Feuz (2002) conducted a simulation analysis to analyze the effects of altering 
days on feed to achieve different carcass goals relative to different pricing structures. In 
general, the author found that it was profitable to increase DOF due to the improvement 
in quality grade and overall increase in pounds sold, which offsets the discounts for 
undesirable yield grades and increased feed costs. The opposite was found in cattle that 
were fed for two fewer weeks. Due to the loss in HCW, as well as no quality grade 
advantage, there was a negative return in all scenarios that were simulated. The author 
concluded that HCW is the driving factor in profitability and cattle should be fed longer 
to achieve more revenue from more marketed pounds. Wilken et al. (2015) further 
expanded on these ideas. Utilizing regression analysis, the author found that dressing 
percentage increased linearly through the feeding period and could be utilized to predict 
carcass weight from shrunk body weight at any point during the feeding period. 
Additionally, the analysis found that BW and HCW increased linearly. However, while 
live BW gain decreased during the feeding period, carcass weight gain remained 
constant. Further utilizing regression analysis, the carcass weight gain expressed as a 
percentage of BW gain, it is concluded that weight gain is transferred to the carcass 
linearly and approached 100% as it approached the end of the feeding period. The author 
concluded that producers should feed cattle fewer days if selling on a live basis to 
overcome losses in live gain and efficiency but should feed cattle longer if selling on a 
carcass basis to maximize revenue potential from additional HCW.  Wilken et al. (2015) 
further concluded that carcass feed efficiency decreases linearly on a live basis and 
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quadratically on a HCW basis, which may alter the most profitable time for producers to 
market their cattle on a BW or HCW basis. When modeled at $3.50/bu corn price, the 
BW cost of gain ($/kg) increased quadratically (y= 0.578 + 0.0011x + 0.000008 x2) from 
approximately $1.00/kg to $1.50/kg of gain when cattle were fed for 20% longer DOF. 
The HCW cost of gain responded quadratically (y = 0.93 – 0.002x+ 0.00003 x2), 
suggesting that there is a slight decrease in COG when cattle are marketed early and 
increases as cattle are fed longer DOF. This could be of great importance when feed costs 
are high and margins low, which would promote marketing cattle on a BW basis to 
minimize losses or continuing to feed for 25% longer if marketed on HCW basis, as the 
additional weight from added days minimizes costs for additional DOF.  
Body Measurements 
 Advancements in understanding how carcass composition changes over time 
through serial harvest studies has been instrumental in understanding appropriate times to 
market fed cattle.  Furthermore, body measurements can be useful in improving our 
knowledge of carcass composition and providing more readily available tools to predict 
terminal endpoints. Body measurements and the factors that affect the values, including 
breed type, weight, condition, frame and sex have been studied extensively for over 70 
years and in a review by Bruns and Pritchard (2003), their influence on body 
measurements, either alone or in combination, are described in detail.  
 Although weight has been the primary method for how producers gauge 
performance, there have been many research results that have confirmed that weight is 
related to frame, backfat and muscling of the cattle (Bruns and Pritchard, 2003). Dolezal 
et al. (1993) found that increased age of feeder cattle and decreased frame size was 
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associated with fewer DOF. When muscle thickness was evaluated, No. 3 steers, or steers 
with less muscling, required more days on feed with no differences between No. 1 or No. 
2 steers. However, these effects were not consistent among age or frame size subclasses 
and cannot be applied to all groups of cattle. Tatum (1986) conducted an objective 
analysis on the effects of frame size and muscularity to describe morphological 
differences in yearling cattle. It was found that there was a strong correlation (r = 0.96) 
between frame size and mature body weight at any age. Additionally, the author 
concluded that 95% of variation among subclasses of cattle can be described by two 
criteria: differences in frame size and dimensional variation corresponding to differences 
in muscularity.  
 Ultrasound technology has proven to be useful in helping predict carcass 
composition using objective measurements at various stages in the feeding period without 
having to utilize serial harvest methods.  Ultrasound systems have allowed researchers 
and producers to estimate backfat thickness quickly, which is vital because backfat has 
been recognized as the single best parameter for estimating carcass yield grade and 
composition. Because backfat thickness increases at definite rates, it can be useful to 
project future cutability grades, especially in research protocols (Brethour, 1992). 
Additionally, ultrasound technology has been found to be reliable and accurate, with 
carcass and ultrasound traits positively correlated in a moderate to high magnitude (r= 
0.76-0.93; Brethour, 1992). Aside from predicting carcass composition or yield at a 
certain time point, ultrasound technology can be used to sort and select cattle prior to the 
finishing phase to better predict an optimal endpoint (Basarab et al., 1999). However, 
ultrasound technology doesn’t come without some limitations, and may underestimate 
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backfat thickness in fatter cattle and overestimate fat thickness in leaner cattle (Williams, 
2002) and is time and labor intensive. 
 Basarab et al. (1999) evaluated the effect of sorting by weight or sorting by a 
system that utilizes a combination of weight, ultrasound backfat thickness and marbling 
score, on the subsequent effects of performance and carcass merit. The author found that 
using a sorting system utilizing parameters estimated from ultrasound technology 
clustered cattle into more uniform feeding and marketing groups prior to the finishing 
phase. In addition, the more uniformly sorted cattle showed positive effects on growth, 
feed efficiency, and carcass yield and quality grades. With these observed benefits, the 
author estimated that ultrasound technology could increase profitability by greater than 
$21.44 per head.  
 Unfortunately, the cost of implementation, labor of licensed technicians, and 
repeatability of measurements remain major barriers. Houghton and Turlington (1992) 
defined the two biggest limitations of the repeatability of ultrasound as the population 
variation influence on correlation coefficients (either over- or underestimating), 
correlation coefficients not describing bias from different techniques, technicians or other 
sources, and producers not appropriately understanding how to interpret correlation 
coefficients. The authors also reported that there can be much variation in ultrasound 
results caused by differences in hide thickness, hair, and degree of fat at the point of 
ultrasound measurements. Williams (2002) reported that backfat measurements using 
ultrasound were more reliable because they were one dimensional, whereas LM area is on 
different planes.  Ultrasound also requires clipping of hair at the point the measurement is 
to be taken, application of oil, and multiple measurements to predict LM area and 
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backfat, which is added time and expense in addition to the training or hiring of a 
certified technician. MacDonald et al (2006) suggested that the cost of implementing 
ultrasound is minimal on a per head basis if a large number of animals are measured, but 
if a fewer number of animals are ultrasounded late in the finishing phase, potential 
performance decreases may become cost inhibiting. While subjective and objective 
measurements have been useful in sorting cattle into more uniform marketing groups, 
there may be simpler and cost-effective methods to predicting carcass composition and 
ideal marketing times. 
Importance of Weight 
  As previously discussed, researchers frequently want to determine the differences 
in carcass composition among live animals or carcasses on different treatments, but 
sacrificing live animals is not always a feasible option (Hedrick, 1983). Therefore, it has 
been accepted that weight has the most impact among measurable variables in predicting 
carcass composition in a live animal and can explain up to 60% of the variation in ADG 
throughout the animal’s lifetime (Hammock and Shrode, 1986; Feuz, 2002).  
 Simpfendorfer (1974) summarized the relationship and impact of BW on carcass 
composition of British beef breeds from birth through maturity. The author found that 
cattle with similar mature sizes, 95.6 to 98.9% of variation in chemical components and 
empty body energy of the carcass was accounted for by variation in body weight. This 
relationship has allowed for the formulation of different equations and computer models 
that account for the variation of BW on final carcass composition (NASEM, 2016). Perry 
and Fox (1997) utilized 120 steers representing different breeds to further determine a set 
of predictive equations to depict carcass fat percentage and yield grade in live cattle to 
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optimize sale points. Steers were fed to reach a carcass endpoint of 275, 300 or 360 kg. 
Live carcass measurements were taken using ultrasound and carcass measurements were 
taken at a commercial harvesting facility after a 24-h chill. Using these measurements, 
the authors were able to construct a set of equations that predict carcass and empty body 
composition, which allows for producers to determine incremental cost of gain and 
predict quality and yield grade to optimize the conditions in which cattle are marketed.  
 Cooper et al. (1999) found a relatively strong correlation (r = 0.46 to 0.86) 
between weight at reimplant and HCW, which allows for the ability to potentially 
identify overweight carcasses at the time of reimplant. While manual palpation or 
ultrasound was successful in predicting carcass weight in this trial, identifying yield 
grade concerns and estimating back fat was not successful. The author concluded that 
ultrasound accounted for 15 to 25 percent of the variation in carcass fat thickness, while 
manual rib palpation explained between 5 and 12 percent of carcass fat variation.  
 MacDonald et al. (2006) demonstrated through different sorting systems that 
cattle that were sorted based on BW prior to the finishing phase and then marketed at 
different end points based on BW were more successful than other more expensive 
sorting methods. The author suggested that sorting on BW alone likely allows producers 
to reduce discounts on overweight carcasses and feed lighter animals for more days to 
gain additional HCW.  
 Overall, BW has been shown to be a feasible and accurate measurement to predict 
optimal HCW and marketing date. It is the easiest, and potentially most cost effective, 
measurement to obtain that can provide the most application to feed yard personnel.  
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Conclusions 
  Exogenous steroid implants have been approved and extensively used in the 
feedlot industry over the last 50 years. Nearly all cattle entering the feedlot receive at 
least one implant during the finishing phase. These implants help cattle increase the 
amount of protein deposited and HCW, and delays the rate of fattening, therefore, 
increasing yield grade and potentially decreasing quality grade. Additionally, implants 
improve feed efficiency and ADG. There are many different options feedlots can use and 
adapt to fit their implant program, therefore giving them the flexibility to find a program 
that fits their goals and maximizes their return on investment (Nichols et al., 2009). With 
the increases in performance and HCW, implants allow feedlots to sell more total retail 
product, potentially making the supply chain more profitable.  
 In addition to implants, serial harvest studies have helped with understanding how 
cattle deposit protein and fat relative to DOF. As cattle are fed longer DOF, ADG and 
feed efficiency decrease, while live BW and HCW increase. This allows more saleable 
product, which, in general, minimizes the costs associated with feeding extra DOF.  
 The beef industry is constantly evolving and adopting innovative technology to 
increase efficiency and profitability of fed cattle while also feeding for longer DOF when 
market conditions allow. Therefore, the objectives of these studies were: to evaluate the 
effects of coated long-acting, delayed release implants in heifers fed for constant DOF or 
the effect of traditional, aggressive implant strategies compared to long lasting implants 
when heifers are fed varying DOF (Exp. 1 and 2) and evaluate and define the optimal 
time to reimplant heifers and steers following a mild initial implant (Exp. 3 and 4).  
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Abstract 
 Two experiments evaluated the effect of delayed and long-lasting implant 
strategies for finishing heifers. In Exp. 1, heifers (n=500; initial BW = 280; SD = 21 kg; 
10 pens/treatment) were utilized in a generalized randomized block design to evaluate the 
effects of coated trenbolone acetate (TBA) and estradiol (E2) implants (Merck Animal 
Health, De Soto, KS) on growth performance, carcass characteristics, and serum 
metabolites when heifers are fed for 198 d. The five treatments included no implant 
(CON), Revalor-XH on d 1 (200 mg TBA/20 mg E2, partially coated; XH), Revalor-200 
on d 1 (200 mg TBA/20 mg E2, noncoated; E200), Revalor-XR on d 1 (200 mg 
TBA/20mg E2, coated; XR) or Revalor-200 on d 70. (D200). Blood was collected on d 1, 
35, 70, 105, 140, and 175 and sera was harvested for further analysis of blood urea-N 
(BUN), IGF-1, 17β-trenbolone (17β-TbOH) and NEFA concentrations. Implanted heifers 
were heavier, gained more, and were more efficient (P ≤ 0.03) compared to CON, but no 
differences were observed between implant treatments (P ≥ 0.21). Implanted heifers had 
greater HCW and dressing percent, but lower marbling scores compared to CON (P ≤ 
0.04), with no differences between implant treatments (P ≥ 0.38). Blood urea-N levels 
increased as days on feed (DOF) increased (P < 0.01), NEFA levels decreased as DOF 
increased (P < 0.01), and IGF-1 levels increased as DOF increased (P < 0.01), regardless 
of implant treatment. There was an implant × time interaction (P < 0.01) for 17β-TbOH 
respective to the implant’s release pattern and payout. In Exp 2., calf-fed heifers (n = 720; 
initial BW = 281; SD= 10 kg; 6 pens/treatment) were utilized in a 3 × 4 factorial 
arrangement with 3 implant strategies and 4 serial harvest dates. Implant treatments 
included no implant (CON), Revalor-200 on d 1 followed by Revalor-200 on d 100 
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(200), or Revalor-XH (XH) on d 1. Serial harvest days included 151, 165, 179, and 193 
DOF. There were no serial harvest × implant treatment interactions (P ≥ 0.23) for growth 
performance or carcass characteristics (P ≥ 0.31). Final BW increased linearly (P < 0.01) 
ADG tended to decrease linearly (P = 0.10), and G:F decreased linearly (P = 0.02). Fat 
depth, marbling score, and yield grade increased linearly (P < 0.01) as DOF increased. 
Implanted heifers had heavier HCW, gained more, and were more efficient compared to 
CON (P ≤ 0.04).  Non-implanted heifers had greater USDA marbling score (P < 0.01) 
compared to implanted cattle, and XH tended to have a greater marbling than 200 (P = 
0.10). Implanting and increasing DOF substantially increased HCW but increasing initial 
implant dosage did not result in a performance advantage when heifers were fed for 
varying DOF. 
Keywords: Implants, Payout, Serial Harvest 
Introduction 
 Growth promoting implants have been proven to be a safe and effective tool in the 
feedlot industry to increase gain and hot carcass weights in steers and heifers (Duckett et 
al., 1997; Bruns et al., 2005; Folmer et al., 2009). Implants obtain this response by 
increasing frame size and delaying fattening, which requires cattle to be fed to longer 
days on feed (DOF) to achieve similar empty body fat percentage as non-implanted cattle 
(Reinhardt, 2007; Smith et al., 2017).  
 Traditional, uncoated combination implants have a payout period of 60 to 120 d 
(Mader, 1998), which then requires reimplantation if cattle are fed for over 120 d. More 
recently, beef producers have been feeding for longer DOF, which can cause logistical 
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issues for reimplanting strategies. The FDA has approved coated implants in the last 
decade that can be used for cattle fed for 200 d post implantation. Coating technology on 
these implants can delay the partial or entire dose of steroids until approximately 70 to 80 
d after implantation, which can deliver similar performance as a traditional initial implant 
given on arrival followed by a terminal implant approximately 100 d prior to slaughter. 
For example, Nichols et al. (2014) reported no differences in final BW, ADG, G:F or 
carcass characteristics for steers given either an initial implant + terminal implant or one 
partially coated implant of the same hormonal concentration and fed for 157 d. Therefore, 
the objective of this study was to evaluate feedlot and carcass performance of long-fed 
heifers given new partially-coated (Revalor-XH) or fully coated (Revalor-XR) implant 
program, compared to traditional implant strategies or no implant and fed for similar or 
varying DOF.  
Materials and Methods 
 All procedures used in these experiments were reviewed and approved by the 
University of Nebraska- Lincoln Institutional Animal Care and Use Committee (IACUC).  
Experimental Design and Procedures: Exp. 1 
 Crossbred heifers (n = 500; initial BW = 280; SD = 21 kg) were utilized in a 
generalized randomized block design with 2 initiation blocks and 2 BW blocks within 
start time. Heifers were assigned randomly to one of 50 pens (10 heifers/pen) and pens 
were assigned randomly to one of five treatments. Treatments included: no implant 
(CON), Revalor-XH on d 1 [200 mg trenbolone acetate (TBA) and 20 mg estradiol (E2), 
partially coated (XH); Merck Animal Health, DeSoto, KS], Revalor-200 on d 1 (200 mg 
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TBA/20 mg E2, Merck Animal Health, noncoated; E200), Revalor-XR on d 1 (200 mg 
TBA/20mg E2; Merck Animal Health, coated; XR) or Revalor-200 on d 70 (200 mg 
TBA/20 mg E2; Merck Animal Health, noncoated; D200). All implants contained 10 
pellets (20 mg TBA/2 mg E2 per pellet), but coating technology varied among implants. 
Revalor-XR contained 10 coated pellets that are designed to be released approximately 
70 to 80 days after implanting. Revalor-XH contains four uncoated pellets (80 mg TBA 
and 8 mg E2) for immediate release and 6 coated pellets (120 mg TBA and 12 mg E2) to 
release approximately 70 to 80 d after implanting.  
 Heifers were sourced from auction markets and transported to the University of 
Nebraska Eastern Research and Extension Center (ENREC) research site located near 
Mead, NE. At the time of feedlot arrival, all heifers were individually identified (panel 
tag, electronic button, and metal clip). All heifers received an infectious bovine 
rhinotracheitis (IBR) virus, parainfluenza-3 (PI3) virus, bovine viral diarrhea (BVD) virus 
(types I and II), bovine respiratory syncytial virus (BRSV), Mannheimia haemolytica and 
Pasteurella multocida combination vaccine (Vista Once, Merck Animal Health), a 
Clostridium chauvoei, specticum, novyi, sordellii, perfringens Types B, C, and D 
bacterin-toxoid (Vision 7, Merck Animal Health), a 10 percent fenbendazole oral 
suspension for the control of lung worms, stomach worms, and intestinal worms (Safe-
Guard Dewormer, Merck Animal Health), a synthetic prostaglandin to induce luteolysis 
(Estrumate, Merck Animal Health), and one percent doramectin injectable for treatment 
and prevention of gastrointestinal and external parasite control (Dectomax, Zoetis Inc., 
Florham Park, NJ). 
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 Before initiation of the trial, heifers were limit fed at 2% of BW for 5 d a diet 
consisting of 50% Sweet Bran (Cargill Corn Milling, Blair, NE) and 50% alfalfa hay 
(DM basis) to minimize variation in gastrointestinal fill (Watson et al., 2013). Heifers 
were weighed (Silencer Squeeze Chute; Moly Mfg. Inc., Lorraine, KS: scale readability ± 
0.45 kg) two consecutive days (d 0 and 1) to establish initial BW. Heifers were blocked 
by d 0 BW (light and heavy), stratified by BW within blocks and assigned randomly to 
pen within block. Initiation of trial was also used as a block, with 2 starting dates 1 week 
apart and 25 pens starting each week. Pens were assigned randomly to one of five 
treatments with 10 pens per treatment. Light and heavy blocks consisted of four 
replications and one replication, respectively, for block one and one replication and four 
replications, respectively, for block two. On d 1 (May 20, 2016 for block 1 and May 27, 
2016 for block 2) heifers were implanted with their respective treatment. Implants were 
administered in the middle one-third of the ear using a Revalor implant gun (Merck 
Animal Health). Sentinel heifers (n = 3 heifers/pen; 30 heifers/treatment) were identified 
prior to initiation of the study based on the average of the d 0 and d 1 BW measurements. 
The 3 heifers/pen with an average d 0 and d 1 BW closest to the mean BW of their home 
pen were selected for blood collection. Blood samples were taken via tail venipuncture 
from sentinel heifers prior to feeding on d 1, 35, 70, 105, 140 and 175 using BD 
Vacutainer Serum collection tubes (BD, Franklin Lakes, NJ). If tail venipuncture was 
unsuccessful, jugular venipuncture was used. Whole blood samples were allowed to clot 
at 4° C for 24 h prior to sera harvest to be used for quantifying circulating concentrations 
of blood urea-N (BUN), non-esterified fatty acid concentration (NEFA), IGF-1, and 17β-
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TbOH. On blood collection days, cattle were also individually weighed in the morning 
prior to feeding to establish interim performance.   
 All heifers were adapted to a common finishing diet over a 24-d period consisting 
of four adaptation diets. The amount of wet distiller’s grains (WDGS), Sweet Bran, and 
supplement were held constant at 15%, 25% and 4% (DM basis) of the diet, respectively. 
The amount of dry rolled corn (DRC) and high moisture corn (HMC) were gradually 
increased while replacing alfalfa. The first adaptation diet consisted of 11% DRC, 0% 
HMC, and 45% alfalfa hay and was fed for 5 d. The second adaptation diet was fed for 5 
d and consisted of 18.3% DRC, 2.8% HMC and 35% alfalfa hay. The third adaptation 
diet included 23.3% DRC, 7.7% HMC and 25% alfalfa hay and was fed for 7 d. The 
fourth and final adaptation diet included 28.3% DRC, 12.7% HMC, and 15% alfalfa hay 
and was fed for 7 d. The finishing diet included 32.3% DRC, 16.2% HMC, and 7.5% 
grass hay, replacing alfalfa hay.  
 Heifers were housed in open feedlot pens with approximately 91 cm of linear 
bunk space and 56 m2 pen space per heifer. Feed bunks were assessed once daily at 
approximately 0600 for presence of feed. Feed amounts were increased or decreased 
daily to maintain an ad libitum bunk management approach. Cattle were fed once daily 
between 0700 and 0900 and had ad libitum access to fresh water and respective diet. 
Diets were mixed and delivered using a truck-mounted feed mixer and delivery unit 
(Roto-Mix model 420, Roto-Mix, Dodge City, KS). Weekly samples of ingredients were 
collected by University personnel, composited by month, and sent to a commercial 
laboratory (Ward Laboratories, Inc., Kearney, NE) to determine CP (Padmore, 1990a; 
Padmore, 1990b; Gavlak et al., 1996, LECO Corporation), NDF (Mertens, 1992; 
50 
 
ANKOM Technology, 1996; ANKOM Technology, 1998), calcium (Campbell and 
Plank, 1991; Kovar, 2003), and phosphorus (Campbell and Plank, 1991; Wolf et al., 
2003; Kovar, 2003) content of individual ingredients. When refusals were present, orts 
were weighed, sampled and frozen for later analysis of DM. Dry matter of orts were 
determined by placing samples in a 60° C forced-air oven for 48 h (AOAC Method 
935.29; AOAC, 1999). Cattle were visually evaluated daily by trained UNL personnel. 
Evaluations include proper functionality of water tanks, integrity of fences and feed 
bunks, and any abnormal behavior of the cattle. When heifers were determined to be sick, 
heifers were removed from the pen and taken to the processing facility for diagnosis and 
appropriate treatment and then returned to their home pen.  
 On day of shipping, heifers were offered 50% of the previous day’s called feed.  
In the afternoon, all heifers were brought to the handling facility, pen weighed to 
determine final live BW, and loaded onto trucks. All animals were harvested at a 
commercial harvest facility (Greater Omaha Packing, Omaha, NE) after 194 d (Block 1) 
or  201 d (Block 2) on feed. Hot carcass weight and liver scores were recorded on day of 
harvest. After a 48-h chill, LM area, 12th rib fat thickness, and USDA marbling score 
were recorded. Yield grade was calculated (USDA, 2016) from the following formula: 
2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – 
(0.0496 x LM area, cm2). Live final BW was pencil shrunk 4% to calculate dressing 
percentage and live performance. A common dressing percentage of 63% was used to 
calculate carcass adjusted final BW, ADG, and G:F.  
Serum Metabolite Analysis 
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Whole blood samples were centrifuged at 1,250 × g for 20 min at 4 degrees C. 
Serum was then harvested from each tube and approximately 2 mL allocated in one of 
three tubes. Two tubes were then frozen at -20° C for later analysis of blood urea-N 
(BUN) and non-esterified fatty acids (NEFA). One tube was frozen at -80° C for analysis 
of 17β-TbOH and IGF-1 concentrations. 
 Urea-N was analyzed using sera by animal and day using an adapted procedure 
from Smith and Murphy (1993) and quantified using spectrometry and fitted to a standard 
dilution curve. Standard dilution curve was between 0 and 30 mg/dL. Samples were run 
in duplicate and considered for re-runs if the coefficient of variation between duplicates 
was greater than 10%. Non-esterified fatty acid was analyzed using an in vitro enzymatic 
colorimetric method assay (HR Series NEFA-HR, Wako Pure Chemical Industries, Ltd., 
Mountain View, CA) and quantified using spectrometry fitted to a standard dilution 
curve. The standard dilution curve was constructed from values ranging from 0 to 1000 
µeq/L. Samples were run in duplicate and considered for reruns if the CV coefficient was 
greater than 10%.    
Circulating sera IGF-1 was quantified via ELISA (Quantikine Human IGF-I 
ELISA, R & D Systems, Minneapolis, MN). The IGF-I assay was analyzed using sera 
pooled by pen and day. Prior to analysis raw sera samples were extracted to reduce IGF 
binding protein interference. The standard curve constructed for the IGF-I assay was 
between 9.4 and 600.0 ng/mL. Samples were run in duplicate and determinations were 
considered for re-runs if the CV between duplicate samples were greater than 10%.   
Circulating 17β-TbOH concentration was quantified via liquid chromatography-
tandem mass spectrometry (LC-MS/MS) using slight modifications to the 
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procedures described by Blackwell et al. (2014). The 17β-TbOH assay was conducted 
using sera pooled by pen and day, while, sera from all heifers in CON were pooled by 
block and day. In 15 mL conical screw top tubes, equal volumes of methyl-tert-butyl-
ether (MTBE) and sera (2 mL) were spiked with 10 ng of internal standard (17β-
trenbolone-d3, National Institute for Public Health and the Environment of the 
Netherlands), then placed in an orbital shaker at 300 rpm for 30 min at room temperature. 
Samples were centrifuged for 5 min at 1500 × g to separate sera and MTBE layers. The 
MTBE layer was removed and then transferred to 100 × 16 mm borosilicate glass tubes 
and evaporated to dryness at 35°C under a gentle stream of nitrogen. Samples were 
reconstituted in 4 mL 80:20 methanol: water (HPLC grade, Fisher Scientific, Hampton, 
NH). Next, 3 mL of hexane (HPLC grade, Fisher Scientific) was added to the 
reconstituted samples and samples were vortexed for 30 s. Following the vortex step, 
samples were centrifuged at room temperature for 5 min at 1500 × g in order to separate 
the water: methanol mixture from the hexane layer, the hexane layer (top) was then 
discarded, and the hexane wash was repeated. Samples were then dried to a volume of 
less than 0.5 mL under a gentle stream of nitrogen at 35°C, and 3 mL of 5:95 methanol: 
water + 0.1% ammonium hydroxide was added to each sample prior to SPE 
cleanup. Oasis MAX cartridges (3cc/60 mg; Waters Corporation, Milford, 
MA) were conditioned with 3 mL of methanol and 3 mL of 5:95 methanol: water + 0.1% 
ammonium hydroxide, samples were passed through, and cartridges were washed with 2 
× 3 mL 5:95 methanol: water + 0.1% ammonium hydroxide.  Cartridges were then 
allowed to dry under vacuum for 10 min, and samples were eluted into clean 16 × 100 
mm borosilicate glass tubes with 7 mL of methanol. The samples were then evaporated to 
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dryness at 35°C under a gentle stream of nitrogen and reconstituted in 100 µL of 
60:40 methanol: water. The reconstituted sample was passed through a 0.45 
µM polypropylene filter into fixed-insert microvials, capped, and stored at -20°C 
until analysis. Blank (n = 3) and spiked (n = 3) matrix (bovine serum, Sigma-Aldrich, St. 
Louis, MO) samples were analyzed along with 42 unknowns per sample batch (48 
extractions in total) in order to monitor extraction method performance. No steroids were 
observed above the limit of detection in any solvent or matrix blank. The mean matrix 
spike recovery (n = 18) for sera was (112.3 ± 20.79%)   
Quantification of 17β-TbOH was performed via triple quadrupole LC-
MS/MS (TSQ Endura, ThermoFisher). Chromatography was performed 
using a methanol: water gradient elution taken from Blackwell et 
al. (2013) and a Gemini-NX C18 column (150 x 2.0mm; Phenomenex, Torrance, CA) 
with a sample injection volume of 10 µL. Ionization was performed using atmospheric 
pressure chemical ionization in positive mode. Solvent blanks and check standards were 
included every 8 and 16 samples, respectively, in instrument runs for quality control 
purposes.  The limit of quantification, as determined by the lowest calibration standard 
included in sample runs, was 25 pg/mL serum. Values below the limit of quantification 
were assigned a value of 12.5 pg/mL serum which was half the value of the lowest 
calibration standard. 
Statistical Analysis: Exp. 1  
 Animal performance and carcass characteristics were analyzed as a generalized 
randomized block design using the MIXED procedure of SAS (Version 9.4; SAS 
Institute, Inc., Cary, N.C.) with pen as the experimental unit. Heifers that were removed 
54 
 
or died during the experiment were not included in the analysis. The model included 
treatment and block as fixed effects. Treatment means were separated using LSD test 
when the overall F-test was significant. Quality and yield grade distributions were 
analyzed using the GLIMMIX procedure of SAS using a multinomial approach.  
 Blood urea-N, NEFA, 17β-TbOH, IGF-1, and estradiol-17β were analyzed using 
the proc GLIMMIX procedure in SAS as a repeated measure. Treatment, time, and 
treatment × time interaction was included in the model as fixed effects and block was 
treated as a random effect. Treatments were analyzed for differences at time point 0, but 
time point 0 was not included in the model.  For all variables, alpha values < 0.05 were 
considered significant and tendencies were discussed when alpha values were 0.05 ≤ P ≤ 
0.10.  
Experimental Design and Procedures: Exp. 2 
 A feedlot trial was conducted at the Panhandle Research and Extension Center 
near Scottsbluff, NE utilizing 720 crossbred calf-fed heifers (initial BW = 281; SD = 10 
kg) arranged in a 3 × 4 factorial design. Heifers were assigned randomly to one of twelve 
treatments consisting of three implant strategies and four serial harvest groups. Implant 
strategies included a non-implanted negative control (NON), a re-implant strategy 
providing an initial implant containing 200 mg trenbolone acetate and 20 mg estradiol 
(Revalor-200, Merck Animal Health) followed by another implant containing 200 mg 
trenbolone acetate and 20 mg estradiol (Revalor-200, Merck Animal Health) at 100 days 
on feed (200/200), and a delayed release implant strategy providing an initial implant 
containing 200 mg trenbolone acetate and 20 mg estradiol (Revalor-XH, Merck Animal 
Health) at day 0 (XH). The Revalor-XH implant contains ten pellets each with 20 mg 
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trenbolone acetate and 2 mg estradiol, including four uncoated pellets (immediate 
release) and six coated pellets, which served as the delayed release portion of the implant. 
The four serial harvest groups were determined based on time point at which the heifers 
reached appropriate market condition, in which serial harvest groups would be marketed 
at 14 d intervals thereafter. Based on the performance and time at which marketing 
condition was achieved, serial harvest groups consisted of heifers fed to 151 (NORMAL), 
165 (PLUS14), 179 (PLUS28), and 193 (PLUS42) days on feed. The trial utilized 72, 10 
head pens allowing for six replications per treatment (60 heifers per trt).  
On arrival, all heifers were identified and processed. During the identification 
process, heifers received a panel tag in the left ear with an individual identification 
number and a metal tag in the right ear with corresponding identification number. All 
heifers received a Clostridium chauvoei, specticum, novyi, sordellii, perfringens Types B, 
C, and D bacterin-toxoid (Vision 7; Merck Animal Health) for prevention of disease 
caused by Clostridium chauvoei (Blackleg), septicum (Malignant edema), novyi (Black 
disease), sordellii and perfringens Types C&D (Enterotoxemia) and 2 mL Vista Once 
subcutaneous (Merck Animal Health) for the prevention of respiratory disease caused by 
IBR, BVD (Type 2), and BRSV and as an aid in the control of disease caused by BVD 
(Type 1), PI3, Mannheimia haemolytica and Pasteurella multocida. Upon processing on d 
0, heifers also received 14 mL fenbendazole oral drench (Safeguard, Merck Animal 
Health) for removal and prevention of worms. Heifers were housed in pens and limit fed 
until initiation of the trial.  
 Heifers were limit fed step 1 of the step-up ration at 2% BW per day for 5 
consecutive days prior to a 2-d weight collection to minimize variation in gut fill (Watson 
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et al., 2013). On d 0 of the trial, individual BW was recorded, carcass ultrasound images 
were collected, and heifers were assigned randomly to one of twelve treatments within 
three initial start date blocks. Based on treatment assigned, heifers were administered 
their respective implant while in the chute on d 0. Each treatment was represented equally 
within start date block with two replications per block for a total of 24 pens (240 heifers). 
On d 1 of the trial, a pen weight was recorded to serve as the second d weight collection. 
Real time carcass ultrasound images were collected on heifers at initiation of trial, 
100 d (re-implant), and each d of serial shipping for all heifers remaining (151, 165, 179, 
and 193 d). Real time carcass ultrasound measurements including LM area, 12th rib fat 
thickness, and intramuscular fat percent were collected by a Centralized Ultrasound 
Processing (CUP Lab; Ames, Iowa) certified field technician. Images were captured using 
an Aloka 500-V unit (Corormetrics Medical Systems, Wallingford, CT) equipped with a 
3.5-MHz, 17.2 cm linear array transducer. All images were captured on the right side of 
each heifer. To capture 12th rib fat thickness and LM area, the heifer was palpated to 
locate the 13th rib and the transducer was placed laterally between the 12th and 13th ribs 
utilizing a standoff guide to capture the image. Images for intramuscular fat percent were 
collected by placing the transducer three-fourths the distance from the medial end of the 
LM area to the lateral end and horizontally over the 12th and 13th ribs. Ultrasound image 
interpretation was conducted by a certified technician at The CUP Lab. After 
interpretation, ultrasound intramuscular fat percent was converted to USDA marbling 
score utilizing data presented by Wilson et. al. (1999) to allow for comparisons with 
carcass data post-harvest. 
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 During the trial, bunk space was provided at 54.9 linear cm/heifer and pen space 
allotted was 6.1 × 4.3 m which equated to 26.2 m2 per heifer. The step-up period 
consisted of 21 d including three d on step 1, four d on step 2, seven d on step 3, and 
seven d on step 4. The common finishing ration fed to all heifers consisted of 58% dry-
rolled corn, 7% corn silage, 4% wheat straw, 25% wet distiller’s grains plus solubles, and 
6% supplement (DM basis). Heifers were fed once daily and provided ad libitum access 
to feed and water throughout the trial. 
Statistical Analysis  
All data were analyzed using the GLIMMIX procedure of SAS (SAS Institute, 
Inc., Cary, N.C.). Pen was included as the experimental unit and start block was included 
as a fixed effect. The model included implant treatments, serial harvest, and the 
interaction of implant and serial harvest as fixed effects. Treatment × linear serial harvest 
and treatment × quadratic serial harvest were analyzed.  Due to a significant difference in 
initial pen weights among treatments, initial pen weight was considered a possible 
covariate and included in the model. If the covariate was determined to be insignificant 
(P > 0.10) for that variable, initial pen weight was removed from the model as a 
covariate. Pen initial weight was included as a covariate in the model for final and 
carcass-adjusted end BW, final and carcass adjusted ADG, final and carcass adjusted 
G:F, and HCW. Orthogonal contrasts were used to test linear and quadratic effects of 
serial harvest for heifers. Significance was deemed at an alpha value of ≤ 0.05 and 
tendencies were discussed when alpha values were 0.05 ≤ P ≤ 0.10. 
Results and Discussion 
Experiment 1 
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 Heifers were evaluated for missing or abscessed implants on d 35 and 105 and if 
found, were removed from trial. Two heifers were removed for missing implants on d 35 
(one from each block) and one from d 105 (Block 1). No abscessed implants were 
observed. Additionally, there was 1 death and 5 removals in block 2 (3 footrot, 1 navel 
abscess and 1 chronic).  
Overall, there was no effect on DMI (P = 0.22; Table 2.1) due to implant 
treatments over the entire feeding period, which is consistent with observations from 
Duckett et al. (1997) based on DMI as a percentage of on-test BW, potentially suggesting 
that slight changes in DMI with the use of implants is driven by the increase in BW 
(Reinhardt and Wagner, 2014). Using carcass-adjusted performance, implanted cattle 
were 19 kg heavier than CON (P < 0.01), but there were no differences between implant 
treatments (P ≥ 0.87). All implanted cattle had 7% greater ADG compared to CON cattle 
(P < 0.01) which led to implanted heifers being 4% more efficient (P < 0.01). This 
response has been well documented with implant strategies increasing ADG by an 
average of 21% and improving feed efficiency by an average 11%, which is greater than 
what was observed in the current experiment (Duckett et al., 1997; Wileman et al., 2009; 
Johnson et al, 2013).  Kreikemeier and Mader (2004) reported similar results and found 
that implanted heifers were 11.8 kg heavier, gained 0.108 kg/d more and heifers receiving 
a combination implant + melengesterol acetate (MGA) were more efficient than heifers 
receiving a single compound implant or no implant. Heifers implanted with XR, E200 or 
D200 were the most efficient (P < 0.01), but E200 or D200 were not different than XH (P 
> 0.29), and CON was the least efficient (P = 0.01) Comparable results were observed 
when live final performance was evaluated.  
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 Implanted heifers had 11 kg greater HCW than CON (P < 0.01; Table 2.1). This 
response is well documented with an average of 18 to 27 kg of added HCW expected 
from use of a combination implant (Johnson and Chung, 2007; Johnson et al., 2013; 
Reinhardt and Wagner, 2014).  There were no differences in HCW, dressing percentage, 
fat thickness, or USDA marbling score among all implanted treatments (P ≥ 0.38), but 
CON had a lesser dressing percentage and greater marbling scores compared to implanted 
heifers (P ≤ 0.04) in this study when heifers were fed for the same DOF. Kreikemeier and 
Mader (2004) found no differences in USDA marbling score for heifers given estrogenic 
implants, trenbolone acetate implants, or no implant; however, heifers given an 
estrogenic + TBA combination implant had lower marbling scores compared to other 
treatments. Johnson and Chung (2007) reported no effect of implant treatment on fat 
thickness compared to nonimplanted animals fed the same number of days. Heifers 
within XH, XR, and D200 treatments showed an increase in LM area (P < 0.01) 
compared to cattle implanted with E200 or CON, which translated into a lesser calculated 
yield grade (P = 0.04). Previous researchers have suggested that implanting alters 
intramuscular fat deposition and composition due to a dilution effect with increasing LM 
area (Duckett et al., 1999). Duckett and Andrae (2001) found implanting cattle with an 
estrogenic or combination implant reduced marbling score by 4%, but increased LM area 
by 3 or 4%, respectively.   
There was a tendency for a change in the distribution of quality grade (P = 0.10) 
and yield grade (P = 0.07) between implant treatments and CON (Table 2.2). Johnson 
and Chung (2007) noted that the use of growth promotant technologies, such as steroidal 
implants, shift nutrient use towards lean carcass tissue rather than adipose tissue, which 
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leads to 10 to 12% more carcass protein in implanted cattle compared to non-implanted 
controls, which could lead to a shift in yield grade distribution. However, Roeber et al. 
(2000) reported no differences in final yield grade because the increase in HCW was 
offset by the increase in LM area in the calculations used to determine final yield grade. 
Roeber et al. (2000) also reported that the percentage of carcasses grading USDA Prime 
or Choice ranged from 94.4% in non-implanted control steers to 75% in steers that were 
implanted with 200 mg TBA + 28 mg estradiol (Synovex Plus, Zoetis). However, in the 
current study, the effect on percent of heifers grading USDA Choice or Prime was 
minimal (92.5% CON vs 91.3% all implant treatments).  
 Interim performance is summarized in Table 2.3. During the first 70 days of the 
feeding period, heifers implanted with XH and E200 had greater ADG and were more 
efficient (P = 0.01) compared to the other treatments. From days 70 to 140, cattle 
implanted with XR or D200 gained more and were more efficient (P < 0.01) than the 
other treatments, which is consistent with the delayed release of XR and the delayed 
implanting of D200 heifers. From d 140 to d 175, all implanted cattle were heavier than 
CON (P < 0.01). Interestingly, from d 140 to the end of the feeding period, the non-
implanted heifers were more efficient (P = 0.01) than all implanted cattle and the non-
implanted heifers gained more than implanted treatments (P = 0.05).  
 Serum metabolite results are summarized in Table 2.4 and Figure 2.1. There were 
no treatment × time interactions (P ≥ 0.59) or treatment effects (P ≥ 0.12) for BUN, 
NEFA, or IGF-1 circulating concentrations. Blood urea-N concentration increased as 
DOF increased (P < 0.01) from 15.9 mg/dL to 19.2 mg/dL. As DOF increased, NEFA 
levels were decreased (P < 0.01) from an initial level of 330.1 mEq/L on d 1 to 166.9 
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mEq/L on d 175 across all treatments. Similarly, IGF-1 levels increased over time (P < 
0.01) from levels of 50.9 ng/mL at trial initiation to 91.6 ng/mL after 175 d. Smith et al., 
(2018) evaluated sera IGF-1 levels in steers that were implanted with XR, Revalor-XS 
(200 mg TBA + 40 mg E2, partially coated; Merck Animal Health), Revalor-200 on d 1 
or Revalor-200 on d 70 compared to a non-implanted control. Contrary to Exp. 1, 
implanted steers had increased sera IGF-1 steers compared to non-implanted controls 
over 213 d, with levels increasing over time.  Similarly, Dayton et al. (1997) observed 
combination implants increasing circulating IGF-1 concentrations in steers by 40% on d 
40 and 35% after 115 DOF compared to steers that were not implanted.  
 There was an implant treatment × time interaction (P < 0.01) for 17β-TBOh 
levels. At trial initiation, all treatments were below the detection limit of the assay (12.5 
pg/mL) and had no circulating 17β-TBOh. Heifers in CON had no detectable 17β-TBOh 
for the duration of the collections, however, concentrations of 17β-TBOh increased 
markedly after implantation or expected release of coated implants. After 35 d on trial, 
E200 had circulating 17β-TBOh of 121.2 pg/mL, which was significantly greater than all 
other treatments (P ≤ 0.02). However, over the next 35 d period, XR and E200 had the 
greatest levels of circulating 17β-TBOh, but they were not different from each other (P = 
0.14). There was a tendency for XR to be different than XH (72.6 and 45.9 pg/mL, 
respectively; P = 0.06) after 70 DOF. However, on d 105, XR had the greatest circulating 
concentration of 17β-TBOh (147.2 pg/mL), which was not statistically different (P = 
0.14) from D200, which had a circulating concentration of 103.8 pg/mL. On d 140, XR 
and D200 continued to have the greatest circulating concentrations of 17β-TBOh, with no 
statistical differences between treatments (102.2 and 63.4 pg/mL, respectively; P = 0.19). 
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By d 175, XH had returned to baseline (≤ 12.5 pg/mL), while D200 maintained the 
greatest circulating 17β-TBOh concentration at 80.1 pg/mL. These results are comparable 
to those reported by Smith et al. (2018). Henricks et al. (1997) reported that heifers who 
received Revalor-H (140 mg TBA + 14 mg estradiol; Merck Animal Health) had 
increased 17β-TBOh compared to non-implanted heifers until d 84, when all treatments 
containing TBA decreased in serum 17β-TBOh, more so in the Revalor-H treatment. This 
is consistent with the steroidal composition of the coated portion of XH. There were no 
differences between D200 and XR (P = 0.28), and there was no difference between XR 
and E200 (P = 0.38) after 175 DOF.  
Experiment 2 
Initial BW was significant (P < 0.02) and included in the model as a covariate if 
deemed significant. The interactions of treatment × serial harvest, treatment × linear 
serial harvest, or treatment × quadratic serial harvest were not significant (P ≥ 0.23) for 
performance. Implanted heifers had greater final and carcass-adjusted BW compared to 
CON (P < 0.01; Table 2.5), but there were no differences between 200/200 and XH (P ≥ 
0.58). There were no differences in DMI (P ≥ 0.12) among implant treatments. Carcass-
adjusted ADG was greater for implanted heifers compared to CON (P < 0.01), but there 
were no differences between 200/200 and XH (P = 0.55). The increase in ADG from 
implanted heifers led to an improvement in feed efficiency (P < 0.01) compared to CON, 
and 200/200 tended to be more efficient than XH (P = 0.07). As previously discussed, the 
increase in final BW, ADG and G:F observed in implanted heifers compared to non-
implanted heifers has been well documented. However, the lack of statistical significance 
between 200/200 and XH may suggest that a more aggressive initial implant is not of 
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added benefit. Hilscher et al. (2016) evaluated the effects of an initial implant of Revalor-
IH (80 mg TBA + 8 mg estradiol), Revalor-H (140 mg TBA + 40 mg estradiol), or 
Revalor-200 on heifer growth performance. All treatments received Revalor-200 as a 
terminal implant 89 d after initial processing. Similar to the results observed in the 
current study, the author found no differences in final BW, DMI, ADG, or G:F (P ≥ 0.14) 
regardless of initial implant strategy. Additionally, Oney et al. (2018) found no 
differences with increasing implant dose combination on growth performance in calf-fed 
steers.  
Similar to growth performance, there were no serial harvest × implant treatment 
interactions (P ≥ 0.31) for carcass characteristics, however, the interaction of serial 
harvest × implant treatment for backfat tended to be linear (P = 0.12).  Hot carcass 
weight was greater for implanted cattle compared to CON (P < 0.01), but there were no 
differences between implant treatments (P = 0.59). There were no differences in dressing 
percent, LM area, or calculated yield grade among all treatments (P ≥ 0.48), but there 
was a tendency for CON to have less 12th rib fat compared to heifers implanted with 
200/200 or XH (P = 0.10). Cattle accrued backfat linearly (P < 0.01; Table 2.6), but at 
different rates (P < 0.01) respective to implant treatment. The daily accretion rate for 
backfat for non-implanted heifers was 0.000781 (± 0.002251) cm (Figure 2.2). Heifers 
implanted with 200/200 deposited BF at a rate of 0.01735 (± 0.002251) cm per day and 
the daily fattening rate for XH was 0.01294 (± 0.002251) cm. However, it is important to 
note the simple effects are an average over all DOF treatments. Marbling score was 
significantly greater (P < 0.01) for CON, with a tendency for XH to have a greater 
marbling score than 200/200 (P = 0.10). Similar carcass results were reported by Hilscher 
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et al. (2016). The authors found no differences in HCW, LM area, dressing percent, or 
12th rib fat among implant treatments, but the mild initial implant (Revalor-IH) had 
significantly greater marbling scores compared to the higher concentration, more 
aggressive initial implant strategies. Schneider et al (2007) reported no differences in 
carcass characteristics that received varying doses of initial implant and Hutcheson et al. 
(2002) reported no differences in growth performance over the feeding period but 
observed a decrease in marbling score with the use of implants, consistent with our 
findings. Therefore, the use of more aggressive initial implants may not provide growth 
performance incentives during the finishing phase, therefore potentially making it more 
economically sound to use partially-coated, delayed release implants to achieve 
comparable growth performance and increased carcass quality as traditional implant 
protocols without having to reimplant.  
 As heifers were fed for longer DOF, final BW increased linearly from 567 to 613 
kg (P < 0.01), while live ADG and G:F decreased linearly (P < 0.01; 1.89 kg/d vs 1.72 
kg/d; 0.161 vs 0.146). When carcass-adjusted ADG was analyzed, the decrease in ADG 
in heifers fed for longer DOF tended to decrease linearly (P = 0.10), with a lower slope 
compared to live ADG. Carcass-adjusted final BW increased 19 kg in the first 14-d 
harvest period, 29 kg in the next 14-d, and 17 kg in the final 14-d period. Vasconcelos et 
al. (2008) reported similar results and observed a linear increase in final BW and a linear 
decrease in ADG and G:F as steers were fed for 136 compared to 198 d.  As heifers were 
fed from 151 to 193 d, HCW increased linearly (P < 0.01) from 351 kg to 392 kg with the 
greatest increase in HCW coming from d 165 to 179. There were no differences in 
dressing percent (P = 0.49) but there was a linear increase in BF (P < 0.01; Figure 2.2). 
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Likewise, USDA marbling score and YG increased linearly as cattle were fed for longer 
DOF (P < 0.01). Heifers that were fed for longer DOF tended to have a linear increase in 
LM area (P = 0.09). Consistent with our observations, Rathmann et al. (2012) found that 
feeding heifers from 127 d to 167 d increased final BW, decreased ADG, and decreased 
feed efficiency, while having no effect on DMI. Furthermore, the author reported a 22.2 
kg increase in HCW in the first 21 d serial harvest period and a 14.9 kg increase in the 
final 19 d harvest period, while also reporting an increase in 12th rib fat thickness, 
calculated yield grade, and USDA marbling score as heifers were fed for longer DOF.  
 Live weight gain to carcass weight transfer was calculated by dividing the HCW 
slope for DOF treatment by the live final BW slope for DOF treatment. When calculated, 
heifers transferred 89.5% of gain to carcass weight. This means that towards the end of 
the feeding period, for every kilogram of additional BW, approximately 0.9 kg of HCW 
was added (Wilken et al., 2015). This is slightly less than what Wilken et al. (2015) 
concluded in steers, where weight gain transferred to the carcass approached 100% by the 
end of the feeding period. In a review by Streeter et al. (2012), the author concluded that 
the carcass transfer in heifers was 86.6% after the first 21-d serial harvest period, but then 
declined to 65.8% after 42-d serial harvest period.  
 Overall, implanting heifers with aggressive implants or implants with coating 
technology for delayed and extended release had increased carcass-adjusted final BW, 
ADG and were more efficient than non-implanted control heifers. However, the release 
rate (coated, uncoated, or delayed implant) did not affect performance of heifers fed for 
the same DOF (Exp. 1) and a more aggressive initial implant did increase final BW or 
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ADG (Exp. 2). As heifers were fed for increasing DOF, final BW increased linearly, 
while ADG and G:F decreased linearly, with no interaction with implant type.  
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Table 2.1. Performance and carcass characteristics of implanted heifers compared to non-implanted control heifers fed for an average of 198 d (Exp. 
1) 
 Implant Treatment1   Pre-planned Contrasts 
  CON XH E200 XR D200 SEM 
F-
Test 
CON vs 
Implant 
XH vs 
D200 
XR vs 
D200 
Performance           
Initial BW, kg 281 281 280 280 280 8.3 1.00 0.94 0.95 0.99 
Live Final BW, kg 564 581 577 580 577 12.9 0.26 0.03 0.67 0.69 
Adj. Final BW, kg2 561 580 580 580 579 12.5 0.09 0.01 0.87 0.90 
DMI, kg/d 9.7 10.0 9.9 9.8 9.9 0.26 0.22 0.12 0.28 0.47 
Live ADG, kg 1.44a 1.52b 1.51b 1.52b 1.50b 0.044 0.02 <0.01 0.59 0.55 
Live G:F 0.148a 0.151a 0.152ab 0.156b 0.153ab 0.0015 0.02 0.01 0.54 0.13 
Adj. ADG, kg2 1.42a 1.52b 1.52b 1.52b 1.51b 0.039 <0.01 <0.01 0.86 0.84 
Adj. G:F2 0.147a 0.151b 0.153bc 0.156c 0.153bc 0.0015 <0.01 <0.01 0.29 0.21 
Carcass characteristics           
HCW, kg 354 365 365 365 365 7.9 0.09 <0.01 0.88 0.92 
Dress, % 62.7 63.1 63.3 63.0 63.2 0.12 0.18 0.04 0.81 0.43 
LM area, cm2 79.4b 83.9a 80.0b 82.6a 83.2a 0.11 <0.01 <0.01 0.62 0.62 
Marbling Score3 569 537 534 543 529 10.6 0.09 <0.01 0.61 0.38 
Fat depth, cm  1.70 1.65 1.75 1.68 1.63 0.022 0.58 0.70 0.61 0.44 
Calculated YG4 3.80ab 3.64a 3.90b 3.69a 3.61a 0.077 0.04 0.28 0.78 0.47 
a,b,c Means within a row without common superscripts differ (P ≤ 0.05) 
1 Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health; 
XH), 200 mg TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant 
(Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).  
2 Common dressing percentage (63%) used to calculate carcass adjusted performance 
3 USDA Marbling Scores. 400 = small, 500 = modest, 600 = moderate 
4 Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2)
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Table 2.2. Change in quality grade and yield grade distribution of implanted and non-
implanted heifers fed for an average of 198 d (Exp.1) 
 
 Implant Treatment1  
 CON
a, xy XHb, x E200b, y XRab, xy D200b, x 
P-
Value 
Quality Grade, %      0.10 
Prime 14.3 6.2 4.2 9 6.1  
Upper Choice 56.1 55.7 55.4 54.0 49.0  
Low Choice 22.3 26.8 33.2 28.9 35.9  
Select 7.2 10.3 7.1 8.1 9.0  
Standard 0.0 1.0 0.0 0.0 0.0  
Yield Grade, %      0.07 
1 1.0 2.0 0.0 2.0 1.0  
2 16.7 16.7 11.6 12.3 16.4  
3 48.6 42.9 37.8 48.4 45.1  
4 28.6 34.3 42.3 34.2 36.4  
5 5.2 3.0 8.3 3.0 1.0  
    
 
 
 
1 Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg 
estradiol partially coated pellets (Revalor-XH, Merck Animal Health; XH), 200 mg TBA + 20 mg 
estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 
20 mg estradiol coated implant (Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20 
mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200). 
a, b Means within row without common superscript differ (P ≤ 0.05) for quality grade distribution 
x, y Means within row without common superscript differ (P ≤ 0.05) for yield grade distribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 7
3 
 
Table 2.3. Interim growth performance of implanted and non-implanted heifers fed for an average of 198 d (Exp. 1)  
 Implant Treatments1 P-Value 
 
 
 CON XH E200 XR D200 F-Test 
CON 
vs 
Implant 
XR vs 
D200 
XH vs 
D200 
Day 0-70          
Initial BW, kg 281 281 280 280 280 1.000 0.94 0.99 0.95 
Day 35 BW, kg 322 327 332 321 322 0.21 0.43 0.83 0.33 
Day 70 BW, kg 370 379 384 370 370 0.09 0.23 0.96 0.19 
DMI, kg/d 8.8 8.9 8.9 8.6 8.9 0.34 0.55 0.16 0.68 
ADG, kg/d 1.29a 1.42b 1.50c 1.30a 1.31a <0.01 0.01 0.89 0.01 
G:F 0.148a 0.159b 0.169c 0.151a 0.147a <0.01 <0.01 0.28 <0.01 
Day 70-140          
Day 105 BW, kg 426 440 443 436 433 0.13 0.03 0.65 0.30 
Day 140 BW, kg 472a 494b 493b 492b 491b 0.02 <0.01 0.94 0.71 
DMI, kg/d 9.8 10.4 10.3 9.9 10.0 0.07 0.06 0.77 0.09 
ADG, kg/d 1.46d 1.65bc 1.57c 1.74a 1.73ab <0.01 <0.01 0.83 0.08 
G:F 0.149c 0.160b 0.153bc 0.176a 0.173a <0.01 <0.01 0.54 <0.01 
Day 140-End          
Day 175 BW, kg 522a 546b 543b 546b 542b <0.01 <0.01 0.54 0.56 
Final BW, kg 563 580 577 580 577 0.32 0.04 0.70 0.80 
DMI, kg/d 10.6 11.0 10.7 10.8 10.9 0.18 0.06 0.76 0.47 
ADG, kg/d 1.57 1.48 1.43 1.51 1.47 0.23 0.05 0.46 0.82 
G:F 0.149a 0.134b 0.134b 0.140ab 0.134b 0.04 <0.01 0.37 0.93 
a, b, c Means with a row without common superscripts differ (P ≤ 0.05) 
1 Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health; 
XH), 200 mg TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant 
(Revalor-XR, Merck Animal Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200). 
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Table 2.4. Blood sera metabolite concentrations in 35-d increments in implanted or non-implanted heifers fed for an average of 198 d (Exp. 1) 
 Treatment1  P-Value 
 CON XH E200 XR D200 SEM 
Time x 
Treatment Treatment Time Lin. Quad. 
Blood Urea-N, mg/dL     0.82 0.72 0.87 < 0.01 0.75 0.79 
d 12 15.2 16.0 15.9 16.2 16.4       
d 35 13.5 12.9 13.1 13.6 14.3       
d 70 16.0 15.9 15.6 15.7 16.8       
d 105 17.4 17.8 18.1 17.7 16.3       
d 140 16.8 17.0 17.4 16.8 16.4       
d 175 18.6 19.1 19.8 20.2 18.3       
NEFA, mEq/L      14.4 0.59 0.87 < 0.01 0.72 0.50 
d 12 323.5 340.4 311.7 326.8 348.2       
d 35 177.2 173.8 186.1 162.3 172.7       
d 70 180.1 178.2 208.2 195.6 166.8       
d 105 160.8 167.1 174.8 172.8 172.8       
d 140 191.6 166.8 171.1 184.1 189.8       
d 175 142.4 179.0 174.0 164.1 171.7       
IGF-1, ng/mL      7.7 0.99 0.12 < 0.01 0.06 0.05 
d 12 52.2 52.6 53.9 49.2 46.8       
d 35 56.8 71.1 67.4 68.2 66.0       
d 70 73.9 100.6 82.1 85.9 84.1       
d 105 70.7 96.5 87.8 88.0 90.3       
d 140 72.5 95.5 90.6 84.6 88.3       
d 175 82.4 100.1 94.7 86.2 94.5       
17β-TbOH pg/mL3      11.7 < 0.01 < 0.01 < 0.01 <0.01 0.37 
d 12 ND3  ND ND ND ND       
d 35 NDb 53.8b 121.2a 23.2b NDb       
d 70 NDc 45.9bc 116.5a 72.6ab NDc       
d 105 NDc 55.8bc 57.1bc 147.2a 103.8ab       
d 140 NDc 39.9bc 24.0bc 102.2a 63.4ab       
d 175 NDb NDb 21.6b 48.0ab 80.1a       
a, b, c Means within rows without common superscripts differ (P ≤ 0.05) 
1 Implant treatments include: non-implanted negative control (CON), 200 mg TBA + 20 mg estradiol partially coated pellets (Revalor-XH, Merck Animal Health; XH), 200 mg 
TBA + 20 mg estradiol uncoated administered on d 1 (Revalor-200, Merck Animal Health; E200), 200 mg TBA + 20 mg estradiol coated implant (Revalor-XR, Merck Animal 
Health; XR) and 200 mg TBA + 20 mg estradiol uncoated administered on d 70 (Revalor-200, Merck Animal Health; D200).  
2 Days from initiation of trial 
3 ND = Not detectable (12.5 pg/mL) 
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Figure 2. 1 Effects of implant treatment on circulating sera metabolites (Exp. 1).   
a.             b. 
   
   
 
 
 
c.             d. 
 
 
 
  
Time P = < 0.01 
Trt P = 0.87 
Time × Trt P = 0.72 
Time P = < 0.01 
Trt P = 0.12 
Time × Trt P = 0.99 
Time P = < 0.01 
Trt P = < 0.01 
Time × Trt P = < 0.01 
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Figure Description: Effect of implant treatment on sera metabolite concentrations in 
finishing heifers. Treatments included: No implant (CON), Revalor-XH (200 mg TBA + 
20 mg E2, Merck Animal Health, De Soto, KS; partially coated; XH), Revalor-200 on d 1 
(200 mg TBA + 20 mg E2, Merck Animal Health; uncoated; E200), Revalor-XR (200 mg 
TBA + 20 mg E2, Merck Animal Health; coated; XR) and Revalor-200 on d 70 (D200). 
Baseline measurements for 17β-TbOH were less than the lowest detectable level, which 
is 12.5 pg/mL. 
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Table 2.5 Performance and carcass characteristics for heifers implanted with no implant, Revalor-200 on d 1 and re-implanted with Revalor-200 on d 
100, or Revalor XH on d 1 (Exp.2) 
 
  Treatments1      
Item 
NON 200/200 XH SEM 
CON vs 
Implanted 
200/200 
vs XH 
Final Pen BW, kg2, 6 575 597 595 2.8 <0.01 0.98 
Carcass Adjusted Final, kg3, 6 577 598 596 3.0 < 0.01 0.58 
DMI, kg/d 11.6 11.7 11.8 0.1 0.12 0.15 
Live ADG, kg6 1.71 1.84 1.83 0.016 0.04 0.68 
Carcass Adjusted ADG, kg3, 6 1.72 1.85 1.83 0.02 < 0.01 0.55 
Live G:F6 0.147 0.158 0.154 0.0013 < 0.01 0.05 
Carcass Adjusted G:F3, 6 0.148 0.158 0.155 0.001 <0.01 0.07 
HCW, kg 6 364 377 375 2 < 0.01 0.59 
Dress, % 63.2 63.2 63.4 0.002 0.74 0.48 
LM area, cm2 78.1 80 78.7 1.9 0.63 0.67 
12th rib backfat thickness, cm 1.85 1.91 1.91 0.01 0.10 0.94 
Marbling score4 567 533 549 7 < 0.01 0.10 
Calculated YG5 3.98 4.07 4.11 0.11 0.44 0.79 
1 Treatments include: No implant (CON), 200 mg TBA + 20 mg E2 (Revalor-200, Merck Animal Health) on d 1 and re-implanted with Revalor-200 on d 100 (200/200), or 200 mg TBA + 20 mg E2 
(Revalor-XH, partially coated; Merck Animal Health) (XH) 
2 Final Pen BW pencil shrunk 4% 
3 Carcass-adjusted performance calculated by HCW divided by a common dressing percent of 63%.  
4 400 = small, 500 = modest, 600 = moderate 
5 Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2) 
6 Initial BW was used as a covariate in the model  
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Table 2.6. Growth performance and carcass characteristics of heifers fed for 151, 165, 179 or 193 days on feed (Exp. 2) 
 
 
Treatments1 
  
Contrasts 
Item, NORMAL PLUS14 PLUS28 PLUS42 SEM F-Test Linear Quadratic 
Final Pen BW, kg2, 6 567 579 597 613 3.3 < 0.01 < 0.01 0.46 
Carcass Adjusted Final, kg3, 6 558 577 606 623 4.0 < 0.01 < 0.01 0.78 
DMI, kg/d 11.7 11.7 11.8 11.8 0.10 0.72 0.38 0.84 
Live ADG, kg6 1.89 1.81 1.76 1.72 0.02 < 0.01 < 0.01 0.20 
Carcass Adjusted ADG, kg3, 6 1.83 1.79 1.81 1.77 0.02 0.18 0.10 0.99 
Live G:F6 0.161 0.155 0.15 0.146 0.0021 < 0.01 < 0.01 0.25 
Carcass Adjusted G:F3, 6 0.156 0.154 0.154 0.151 0.002 0.1 0.02 0.84 
HCW, kg6 351 363 382 392 2.0 < 0.01 < 0.01 0.79 
Dress, % 62.3 62.8 63.9 64 0.002 0.49 0.13 0.63 
LM area, cm2 77.4 76.1 82.6 80.6 2.6 0.17 0.09 0.99 
12th rib backfat thickness, cm 1.75 1.75 1.96 2.08 0.03 < 0.01 < 0.01 0.09 
Marbling score4 538 521 565 574 8 < 0.01 < 0.01 0.11 
Calculated YG5 3.83 4 4.04 4.34 0.13 0.05 < 0.01 0.60 
1 Treatments include: 151 (NORMAL), 165 (PLUS14), 179 (PLUS28), or 193 (PLUS42) days on feed. 
2 Final Pen BW pencil shrunk 4% 
3 Carcass-adjusted performance calculated by HCW divided by a common dressing percent of 63%.  
4 400 = small, 500 = modest, 600 = moderate 
5 Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x 
LM area, cm2) 
6 Initial BW was included as a covariate in the model  
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Figure 2.2. Effect of implant treatment and DOF on backfat thickness of heifers fed 
varying DOF (Exp. 2) 
A.     
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 Figure Description: Backfat thickness increased linearly (P < 0.01) as cattle were fed 
from 151 to 193 DOF, with no implant treatment × serial harvest interaction (P = 0.26). 
There was a tendency for an implant treatment × linear serial harvest interaction (P = 
0.12). Treatments included: No implant (CON), Revalor-200 (200 mg TBA + 20 mg E2, 
Merck Animal Health, De Soto, KS; uncoated) on d 1 and reimplanted with Revalor-200 
on d 100 (200/200), or Revalor-XH (200 mg TBA + 20 mg E2, Merck Animal Health; 
partially coated; XH). The equations for effect of implant across DOF were: 
 y = 0.00781x (± 0.002251) + 0.6459 (± 0.3888) (P < 0.01; CON), 
y = 0.01735x (± 0.002251) – 0.8880 (± 0.3888) (P < 0.01; 200/200), 
y = 0.01294x (± 0.002251) – 0.1453 (± 0.3888) (P < 0.01; XH). 
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CHAPTER III. Evaluation of day of administration of 200 mg TBA and 20 mg 
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Abstract 
 Two experiments evaluated the optimal time of administration of a terminal 
combination implant following a mild combination implant on finishing heifer and steer 
performance. In Exp. 1, crossbred heifers (n = 1,867; initial BW = 268; SD = 9 kg) were 
utilized in a 181-d finishing study to evaluate the effects of 4 different days on terminal 
(DOT) implant (160, 120, 80 and 40 DOT) on growth performance and carcass 
characteristics. Heifers were given an initial implant of 80 mg trenbolone acetate (TBA) 
+ 8 mg estradiol (Revalor-IH, Merck Animal Health, De Soto, KS) on d 1. Terminal 
implant included 200 mg TBA + 20 mg estradiol (Revalor-200, Merck Animal Health). 
No difference was observed in DMI (P ≥ 0.12), but a quadratic response (P ≤ 0.04) was 
observed for final BW, ADG and G:F, and were greatest for cattle fed 80 DOT when 
carcass-adjusted performance was evaluated. Hot carcass weight was greatest at 80 DOT 
(P = 0.03; quadratic). However, LM area and dressing percentage were greatest at 120 
DOT (P ≤ 0.10; quadratic). Solving for first derivative, each variable was optimized 
between 88 and 103 DOT, with an average of 94 DOT. Interestingly, there was less than 
1% difference in ADG and G:F when implanted 21 days either side of optimal DOT. In 
Exp. 2, crossbred steers (n = 800; initial BW = 330; SD = 25 kg) were utilized in a 180-d 
finishing study to evaluate 160, 120, 100, 80 or 40 DOT on growth performance and 
carcass characteristics. All steers were given an initial implant (80 mg TBA + 16 mg 
estradiol; Revalor-IS, Merck Animal Health) on d 1 followed by a terminal implant 
(Revalor-200, Merck Animal Health). DMI was the lowest for 40 DOT (P ≤ 0.04), with 
no differences between other treatments (P ≥ 0.11). Carcass-adjusted final BW, ADG, 
and G:F responded quadratically (P ≤ 0.05), with 80 to 120 DOT being the greatest, with 
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less than 2% difference over the 40 d period. Hot carcass weight increased quadratically 
(P = 0.03), LM area increased linearly (P < 0.01), and there were no differences in fat 
thickness, marbling score, or calculated yield grade (P ≥ 0.27) as DOT increased. When 
solved for the first derivative, final BW, ADG, G:F, and HCW were optimized between 
87 and 104 DOT. The optimal DOT appears to be between 80 and 120 DOT, with an 
average of 96 DOT for both steers and heifers. These data show flexibility in reimplant 
windows, allowing feedlot personnel flexibility in making management decisions to best 
suit their labor, weather and marketing constraints.  
Keywords: Implants, Payout, Reimplanting 
Introduction 
 Anabolic implants are a proven management tool that have been shown to 
increase performance and efficiency in feedlot cattle for more than 50 years (Hickman et 
al., 1994; Nichols et al., 2002). Since the approval of implants in 1954, many 
combinations of dosage and ratios of steroid hormones have been approved for use in 
cattle (Nichols et al., 2002). However, many implants only last 60 to 120 d until no 
longer effective. Many times, cattle require more than 120 days on feed, which then 
creates the need for two or more implants during the finishing phase to optimize 
performance. When steers were implanted with a combination (trenbolone acetate + 
estradiol) implant as an initial implant and reimplanted with a combination implant, ADG 
was improved by 20% and feed efficiency was improved by 13.5% compared to non-
implanted steers (Duckett and Pratt, 2014). However, with an increased demand for 
improved gains and efficiency, while also feeding cattle longer days on feed, there are 
limited data on the optimal time to administer a terminal implant. Therefore, the objective 
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of these experiments was to identify the optimal time for administering a terminal 
combination implant following a mild combination initial implant in heifers or steers fed 
for approximately 180 d.  
Materials and Methods 
 All procedures used in these experiments were reviewed and approved by the 
University of Nebraska- Lincoln Institutional Animal Care and Use Committee (IACUC).  
Experimental Design and Procedures 
Experiment 1 
 A study was conducted at a commercial feedlot (Barton County Feeders) near 
Ellinwood, KS. Crossbred heifers (n = 1,867; initial BW= 268; SD = 9 kg) were utilized 
in a randomized complete block design with six blocks consisting of 4 adjacent pens per 
block. Heifers were received from 10 sale barns in Kansas (n = 9) and Nebraska (n = 1).  
On arrival, heifers were allowed ad libitum access to fresh water and long-stemmed hay. 
Cattle were randomly allotted to 4 different sort pens (5 animals at a time) until the 
desired head count was achieved in each pen or until there were no more animals in the 
respective purchase group.  In this case, the next purchase group was continued sorting 
into the 4 different pens 5 animals at a time.  This allotment procedure was repeated until 
all pens were filled to a similar bunk space and pen space per animal. Treatments were 
assigned randomly to pens within block and consisted of 4 different days on terminal 
(DOT) implant (160, 120, 80 and 40 d).  
Heifers were received at a commercial feedyard over the course of approximately 
3 weeks and during this time had ad libitum access to water and long-stemmed hay. 
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Heifers were processed according to the standard operating procedures of the facility.  
Heifers were identified with color-coordinated and numbered tags in each ear.  The right 
ear tag contained the lot number and the left ear tag contained the lot number and the 
individual animal ID number.  Heifers were vaccinated for infectious bovine 
rhinotracheitis (IBR), bovine viral diarrhea virus (BVDV) (types 1 and 2), parainfluenza3 
(PI3), bovine respiratory syncytial virus (BRSV), Mannheimia haemolytica, and 
Pasteurella multocida (Vista Once, Merck Animal Health, DeSoto, KS).  In addition, 
heifers received an injection of one percent doramectin for treatment and prevention of 
gastrointestinal and external parasites (Dectomax; Zoetis Animal Health, Florham Park, 
NJ), oral drench of fenbendazole for removal and prevention of worms (Safeguard; 
Merck Animal Health), topical application of one percent lambda-cyhalothrin for the 
control of lice and horn flies (Exile, Aspen Veterinary Resources, Liberty, MO) pour onto 
the back, metaphylaxis injection of an antibiotic for the control of respiratory infection 
caused by Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni 
(Zuprevo, Merck Animal Health), and a growth implant (80 mg of trenbolone acetate + 8 
mg of estradiol, Revlor-IH Merck Animal Health) under the skin of the posterior, middle 
third of the ear. Approximately 15 to 20 days after processing heifers were revaccinated 
for IBR, BVDV types 1 and 2, PI3, and BRSV (Vista 5 SQ, Merck Animal Health). 
Heifers received their terminal implant (Revalor-200; 200 mg of trenbolone 
acetate + 20 mg of estradiol, Merck Animal Health) at 160, 120, 80, and 40 days prior to 
predetermined harvest dates based on assigned treatment.  In addition, heifers were 
revaccinated (Vista 5 SQ, Merck Animal Health) at reimplant. 
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Heifers were housed in 24 dirt-surfaced pens providing 33.3 linear cm of bunk 
space and 22 m2 of pen space per heifer.  Diets were fed three times daily at 
approximately 0700, 1000, and 1350 h. Trained personnel evaluated heifers for overall 
wellbeing daily. Pens within a block were treated the same as it pertains to transitioning 
onto the finishing ration.  Heifers were fed a starter ration, which included 29% steam-
flaked corn, 22.2% WDGS, 38% alfalfa hay, 7% corn silage, and 3.8% supplement (DM 
basis), for 4 to 6 days. Alfalfa hay and corn silage were replaced with steam-flaked corn 
as steps progressed. Heifers were fed half of their diet as the starter ration and half as 
ration 2 for 2 to 4 days before being fed ration 2 alone for 5 to 6 days.  Heifers were then 
transitioned to ration 3 using a 50:50 blend of ration 2 and ration 3 before being fed 
ration 3 alone for 5 to 6 days.  Finally, heifers were transitioned to the finishing ration 
using a 3 to 4-day split feeding of both rations 3 and the finisher. The finisher ration 
included 66.6% steam-flaked corn, 18% WDGS, 4.3% mixed hay, 3.2% corn silage, 
2.9% tallow, and 5% supplement. Supplement was formulated to provide 300 mg 
monensin (Rumensin, Elanco Animal Health, Greenfield, IN), 90 mg of tylosin (Tylan, 
Elanco Animal Health), 0.5 mg of melengestrol acetate (MGA, Zoetis Animal Health), 
and 50 g Bovamine Defend (Nutrition Physiology Company, Overland Park, KS) per 
heifer daily and 250 mg of ractopamine hydrochloride (Actogain, Zoetis Animal Health) 
per heifer daily during the last 28 DOF.  
Heifers were on trial for approximately 181 d prior to harvest.   On the morning of 
shipping prior to feeding, heifers were weighed by pen on a large platform scale.  Heifers 
were then transported to a commercial abattoir located in Holcomb, KS.  Heifers were 
processed on May 24th, 2016 (1 block), June 2nd, 2016 (1 block), June 7th, 2016 (2 
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blocks), and June 14th, 2016 (2 blocks).  Heifers were kept with their pen mates during 
the shipping and harvest process. Trained personnel at the abattoir collected carcass 
measurements using camera grading system.  Carcass weight, liver score, USDA quality 
grade, USDA yield grade, kidney, pelvic, and heart fat, 12th rib fat thickness, LM area, 
and marbling score were collected for each animal at the abattoir.  Average dressing 
percentage was calculated using the total carcass weight and shrunk (4%) final weight of 
the entire pen. Calculated yield grade was calculated using the following: 2.5 + (0.98425 x 
12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2).  
Statistical Analysis Exp. 1 
Growth performance and carcass characteristics were analyzed using the MIXED 
procedure of SAS (9.3, SAS Institute, Cary, NC).  Pen was the experimental unit and 
block was included as a random effect.  Linear and quadratic contrasts of DOT were used 
to compare treatment differences. Treatment averages were calculated using the 
LSMEANS option of SAS. Quality and yield grade distributions were analyzed using the 
GLIMMIX procedure of SAS using a multinomial approach.  Data were considered 
significant at P ≤ 0.05 and a tendency at 0.05 < P ≤ 0.10. 
Experiment 2 
 A feedlot study was conducted at the University of Nebraska Eastern Nebraska 
Research and Extension Center (ENREC) near Mead, NE. Crossbred yearling steers (n = 
800; initial BW = 330; SD = 25 kg), were utilized in a generalized randomized block 
design with two initiation times and three BW blocks within initiation time. Steers were 
sourced from auction markets and transported to the research site. At the time of feedlot 
88 
 
 
 
arrival, all steers were individually identified (panel tag, electronic ear button, and metal 
clip). Steers received an infectious bovine rhinotracheitis (IBR) virus, parainfluenza-3 
(PI3) virus, bovine viral diarrhea (BVD) virus (types I and II), bovine respiratory 
syncytial virus (BRSV), Mannheimia haemolytica and Pasteurella multocida 
combination vaccine (Vista Once, Merck Animal Health), a Clostridium chauvoei, 
specticum, novyi, sordellii, perfringens Types B, C, and D bacterin-toxoid (Vision 7, 
Merck Animal Health), a 10 percent fenbendazole oral suspension for the control of lung 
worms, stomach worms, and intestinal worms (Safe-Guard Dewormer, Merck Animal 
Health), and one percent doramectin injectable for treatment and prevention of 
gastrointestinal and external parasite control (Dectomax, Zoetis Inc.). Five d prior to trial 
initiation, steers were limit fed a common diet of 50% Sweet Bran (Cargill Corn Milling, 
Blair, NE) and 50% alfalfa hay at 2% of BW and weighed for 2 consecutive d (d 0 and 1) 
to establish initial BW and to limit differences in BW due to gastrointestinal fill (Watson 
et al., 2013). Using d 0 weights, steers were blocked by BW (n=3), stratified within 
block, and assigned randomly to pens (n=40). Pens were assigned randomly to one of 
five treatments with 20 steers per pen and 8 pens / treatment.  
 All steers were implanted with 80 mg TBA and 16 mg E2 on d 1 (Revalor-IS, 
Merck Animal Health). Treatments consisted of varying days on terminal implant (160, 
120, 100, 80, 40 d). Terminal implant included 200 mg of TBA and 20 mg of E2 
(Revalor-200, Merck Animal Health). All cattle were implanted under the skin of the 
posterior, middle third of the ear. 
 Steers were adapted to a common finishing diet over a 24-d period consisting of 
four adaptation diets. The amount of wet distiller’s grains (WDGS), Sweet Bran, grass 
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hay and supplement were held constant at 15%, 25%, 6% and 4% (DM basis) of the diet 
DM, respectively. The amount of dry rolled corn (DRC) was gradually increased while 
replacing alfalfa. The first adaptation diet consisted of 12.5% DRC and 37.5% alfalfa hay 
and was fed for 5 d. The second adaptation diet was fed for 5 d and consisted of 22.5% 
DRC and 27.5% alfalfa hay. The third adaptation diet included 32.5% DRC and 17.5% 
alfalfa hay and was fed for 7 d. The fourth and final adaptation diet included 42.5% DRC 
and 7.5% alfalfa hay and was fed for 7 d. The finishing diet included 50% DRC, 15% 
WDGS, 25% Sweet Bran, 6% grass hay and 4% supplement, all on DM basis. The 
supplement was formulated to provide 30 g/ton of monensin (Rumensin, Elanco Animal 
Health) and 8.9 g/ton DM tylosin (Elanco Animal Health).  
 Steers were housed in open feedlot pens with approximately 45.5 cm of linear 
bunk space and 28 m2 of pen space per head. Feed bunks were assessed once daily at 
approximately 0600 for presence of feed. Feed amounts were increased or decreased 
daily to maintain an ad libitum bunk management approach. Cattle were fed once daily 
between 0700 and 0900 and had ad libitum access to fresh water and feed. Diets were 
mixed and delivered using a truck-mounted feed mixer and delivery unit (Roto-Mix 
model 420, Roto-Mix, Dodge City, KS). When refusals were present, orts were weighed, 
sampled and frozen for later analysis of DM. Dry matter of orts were determined by 
placing samples in a 60° C forced-air oven for 48 h (AOAC Method 935.29; AOAC, 
1999). Cattle were visually evaluated daily by trained UNL personnel. Evaluations 
include proper functionality of water tanks, integrity of fences and feed bunks, and any 
abnormal behavior of the cattle. When steers were determined to be sick, steers were 
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removed from the pen and taken to the processing facility for diagnosis and appropriate 
treatment.  
 On day of shipping, steers were offered 50% of the previous day’s called feed.  In 
the afternoon, all steers were brought to the handling facility, pen weighed to determine 
final live BW, and loaded onto trucks. All animals were harvested at a commercial 
harvest facility (Greater Omaha, Omaha, NE) after 180 d on feed. Carcass data collection 
was performed by UNL personnel. Hot carcass weight and liver scores were recorded on 
day of harvest. After a 48-h chill, LM area, 12th rib fat thickness, and USDA marbling 
score were recorded using camera grading. Yield grade was calculated (USDA, 2016) 
from the following formula: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + 
(0.00837 x HCW, kg) – (0.0496 x LM area, cm2). Live final BW was pencil shrunk 4% to 
calculate dressing percentage and live performance. A common dressing percentage of 
63% was used to calculate carcass adjusted final BW, ADG, and G:F.  
Statistical Analysis Exp. 2 
 Growth performance and carcass data were analyzed using the MIXED procedure 
of SAS 9.4 (SAS Institute, Cary, NC). Pen was the experimental unit and BW block, 
initiation block and BW block nestled within initiation block were included as fixed 
effects. Linear and quadratic DOT contrasts were used to compare treatment differences. 
Quality and yield grade distributions were analyzed using the GLIMMIX procedure of 
SAS using a multinomial approach. Data were considered significant at P ≤ 0.05 and a 
tendency at 0.05 < P ≤ 0.10. 
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Results and Discussion 
Exp. 1  
 There were no differences in initial BW between treatment groups (P ≥ 0.18; 
Table 3.1). Dry-matter intake was the same for all treatments (P ≥ 0.12). Using carcass-
adjusted performance, there was a quadratic response to final BW (P = 0.04) and ADG (P 
= 0.01) with 80 DOT having the greatest ending BW and gain, and in turn, being the 
most efficient (P = 0.01; quadratic).   
Figure 3.1 illustrates the quadratic response and the respective regression 
equations of each variable.  Each of these variables were optimized between 88 and 103 
DOT with an average optimal DOT of 94 (87 d on initial implant) when heifers are fed 
for 181 d.  However, growth performance was only reduced by 1% when calculated at 21 
days on either side of the first derivative.  These results suggest that the feedyard operator 
has a 40 d window to move the scheduled terminal implant date around with minimal 
effects of growth performance.   
Interim growth performance data are summarized in Table 3.2.  Interestingly, 
ADG was different between days 0 and 21 (P = 0.02).  These differences were not 
expected and are not due to any treatment effect since the experimental treatment had not 
been applied at this point.  As expected, ADG and G:F were greater (P ≤ 0.05) in each 
period following the day when the terminal implant treatment was applied.  The only 
exception was ADG in the last period when the 40 DOT treatment was applied, in which 
ADG was similar (P ≥ 0.05) between the 80 and 40 DOT treatments.  This may suggest 
that the terminal implant was not fully utilized and had not completely released all the 
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hormones in the last 40 d period. The heifers that received the shortest DOT (i.e., 40) 
treatment also had the longest days on initial implant (i.e., 141 days).  Therefore, the 
ADG response in the 40 DOT treatment may also be due to the terminal implant and less 
response from the initial implant due to length of implant window. 
Carcass characteristics are summarized in Table 3.3. Hot carcass weight and LM 
area responded quadratically (P ≤ 0.03) to DOT, with the greatest HCW response at 80 
DOT and the greatest LM area at 120 DOT. Dressing percentage tended to respond 
quadratically (P = 0.06), with 120 DOT having the greatest dressing percent. 
Interestingly, USDA marbling score increased linearly (P = 0.03) as DOT decreased. 
Bruns et al (2005) observed that cattle implanted with greater doses of TBA + estradiol 
early in the feeding period had in decreased marbling scores, which agrees with our 
observations as marbling score was affected the greatest when cattle received both the 
initial and terminal implant within the first 20 DOF (160 DOT). Contrary to these results, 
Duckett (2004) concluded that reimplanting with a combination implant half way through 
the feeding period resulted in lower marbling scores, therefore contributing the effects on 
marbling to timing of terminal implant administration compared to cattle given only an 
initial implant. Quality grade (P < 0.01) and yield grade (P < 0.01) distributions were 
both altered by days on terminal implant (Table 3.4).  Calculated yield grade did not 
change across treatments (P ≥ 0.25), which does not agree with observations by Duckett 
et al. (1997), who observed decreased yield grades due to decreased fat thickness in 
heifers given two implants.  
Experiment 2 
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 Dry matter intake was the least for 40 DOT (P ≤ 0.04, Table 3.6), with no 
differences between the other treatments (P ≥ 0.11). This agrees with Milton et al. (2000) 
who found that steers either delay implanted or implanted with a combination implant 
and reimplanted with a combination implant 82 d prior to harvest had the greatest DMI 
compared to cattle given a less aggressive dose or only implanted on d 1. Carcass-
adjusted final BW responded quadratically (P = 0.03) with 100 DOT having the greatest 
final BW, but 100 DOT was not different from 120 DOT (P = 0.82). Carcass-adjusted 
ADG responded quadratically (P = 0.02), with 100 and 120 DOT being the greatest, but 
not different (P = 0.87) and 80 DOT being intermediate (P ≥ 0.57).  There was less than 
1% difference in carcass-adjusted ADG between 80, 100 or 120 DOT. When solved for 
the first derivative, ADG was maximized at 99 DOT. Carcass-adjusted G:F also 
responded quadratically (P < 0.01), with 160 DOT being the least efficient, but no 
differences between other treatments (P ≥ 0.13). Compared to 120 DOT, there was a 
1.6% increase in G:F when cattle were reimplanted 100 days prior to harvest and a 0.5% 
increase in G:F for 100 DOT compared to 80 DOT. There was a 1.2% improvement in 
G:F when steers were reimplanted 80 d prior to slaughter compared to 120 DOT. When 
solved for the first derivative, G:F was maximized at 87 DOT. These results disagree 
with Rumsey et al. (1992), where steers implanted 60, 90, or 120 d prior to harvest had 
similar ADG and feed efficiencies regardless of implant protocol. Johnson et al. (2013) 
concluded to gain optimal benefit from an implant, it is vital to utilize the implant until 
most of the hormone has been paid out. 
Interim data are presented in Table 3.7. As expected, ADG and G:F were greater 
in most cases in each period following the day in which the terminal implant was applied. 
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The exception to this was when the 120 DOT treatment was applied. There were no 
statistical differences in ADG or G:F between treatments (P ≥ 0.16), but the 120 DOT 
treatment was not numerically greater compared to the other treatments. There was a 
tendency (P = 0.06) for ADG to be different among treatments during d 82 to 101, 
however, the applied treatment (100 DOT) was not the greatest. Because DMI was the 
lowest for 100 DOT during that period (P < 0.01), 100 DOT did have had the greatest 
G:F during that period (P = 0.02). 
 Carcass characteristics are summarized in Table 3.8. Hot carcass weight 
responded quadratically (P = 0.03), with the greatest at 100 DOT. When solved for the 
first derivative, HCW was maximized at 104 DOT. There were no differences in BF 
thickness (P = 0.81). The lack of differences in subcutaneous fat thickness is consistent 
with most research trials that compare various implant schemes (Duckett, 2004). There 
was a linear increase in LM area as DOT increased, with 100 and 120 DOT having the 
greatest LM area (P ≤ 0.05). Al-Maamari et al. (1995) found when steers received an 
initial combination implant and were reimplanted on d 61 (87 DOT), reimplanted cattle 
had greater amount of salable lean without increasing the amount of fat trim. There were 
no statistical differences in USDA marbling scores (P = 0.27), however, 100 DOT 
numerically had the greatest marbling score. Several other studies show a decrease in 
marbling score with more aggressive implant strategies (Bartle et al., 1992; Platter et al., 
2003; Smith et al., 2007) which may be observed with steers with longer DOT, not giving 
the initial implant enough opportunity to payout. Samber et al. (1996) reported that a 
decrease in intramuscular fat is expected when combination TBA + estradiol implants are 
administered more than once or late in the finishing phase, however that was not 
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observed in this study. In a historical review of the use of implants by Montgomery et al. 
(2001), the authors reported that delayed implanting or using a mild combination implant 
initially prevents negative effects on marbling score because it is thought that 
intramuscular fat deposition happens early in the feeding period. This idea would support 
100 DOT having the greatest numerical marbling score without sacrificing other carcass 
merits. There were no statistical differences observed in calculated yield grade (P = 0.38). 
Likewise, there were no differences in quality and yield grade distribution for DOT (P = 
0.56 and 0.84, respectively; data not shown). Milton et al. (2000) also observed no 
differences for marbling score or the percent of steers grading Choice or better when 
comparing delayed implanting or mild initial implant followed by reimplanting with a 
combination implant.  
 Overall, administering an initial implant at the beginning of the finishing phase 
followed by a terminal implant on average 96 d prior to slaughter increased growth 
performance and carcass characteristics in heifers and steers when fed for approximately 
180 d compared to administering a terminal implant earlier or later in the finishing 
period. However, with minimal changes in performance and carcass characteristics across 
treatments when cattle were reimplanted 80 to 120 d prior to harvest suggests feedlot 
personnel have flexibility in timing of implants with minor impact on performance. 
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Table 3.1 Effect of days on terminal implant on growth performance of heifers fed for 181 d (Exp.1) 
 
Days on Terminal Implant1  P-Value 
Item 160 120 80 40 SEM Linear Quadratic 
Heifers (pens), n (6) 467 (6) 467 (6) 466 (6) 467 
- - - 
Live Performance 
     Initial BW, kg2 257 257 257 258 3.3 0.18 0.85 
     Final BW, kg2 544 548 550 547 4.4 0.44 0.25 
     DMI, kg 8.9 8.7 8.7 8.7 0.11 0.12 0.17 
     ADG, kg 1.59 1.61 1.62 1.59 0.02 0.69 0.07 
G:F 0.179 0.185 0.186 0.183 0.065 0.16 0.02 
Carcass-adjusted performance 
     Initial BW, kg2 257 257 257 258 3.3 0.18 0.85 
     Final BW, kg3 540 545 548 540 4.3 0.33 0.04 
     ADG, kg 1.56 1.59 1.60 1.57 0.02 0.63 0.01 
G:F 0.176 0.183 0.184 0.180 0.065 0.10 0.01 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IH; Merck Animal Health) 
2 Initial and final BW pencil shrunk 4% 
3 Carcass-adjusted final BW calculated by dividing HCW by common dressing percent of 63.75% 
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Table 3.2 Effect of days on terminal implant on interim growth performance of 
heifers fed for 181 d (Exp 1) 
 Days on Terminal Implant1   
  
Item 160 120 80 40 SEM F-Test Lin. Quad. 
Day 1-20   
DMI, kg 6.5 6.4 6.4 6.4 0.19 0.37 0.67 0.73 
ADG, kg/d 2.08a 1.97bc 1.92c 2.06ab 0.09 0.02 0.76 0.16 
G:F 0.313 0.303 0.293 0.318 0.221 0.08 0.93 0.41 
Day 21-61   
DMI, kg 8.3 8.2 8.1 8.2 0.10 0.41 0.46 0.24 
ADG, kg/d 1.65a 1.49b 1.51b 1.50b 0.04 0.01 0.02 0.06 
G:F 0.198a 0.182b 0.186b 0.182b 0.131 0.01 0.04 0.15 
Day 62-101   
DMI, kg 9.2 9.0 9.0 9.2 0.11 0.29 0.96 0.13 
ADG, kg/d 1.63a 1.83b 1.64a 1.63a 0.05 0.01 0.37 0.04 
G:F 0.177a 0.203b 0.181a 0.177a 0.133 0.01 0.26 <0.01 
Day 102-141   
DMI, kg 9.6 9.4 9.4 9.4 0.12 0.16 0.28 0.28 
ADG, kg/d 1.35a 1.39a 1.56b 1.31a 0.06 0.01 0.89 0.02 
G:F 0.140b 0.147ab 0.165a 0.138c 0.284 0.01 0.58 <0.01 
Day 142-181   
DMI, kg 9.5 9.4 9.4 9.2 0.16 0.18 0.26 0.64 
ADG, kg/d 1.48a 1.54a 1.61ab 1.70b 0.06 0.02 0.02 0.77 
G:F 0.156a 0.164ab 0.169b 0.183c 0.204 0.01 <0.01 0.60 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant 
(Revalor-IH; Merck Animal Health) 
a b c Means without a common superscript within a row are different (P ≤ 0.05) 
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Table 3.3 Effect of days on terminal implant on carcass characteristics of heifers fed for 181 d (Exp. 1) 
 
Days on Terminal Implant1  P-Value 
 
160 120 80 40 SEM Linear Quadratic 
HCW, kg 344 348 349 346 2.7 0.32 0.03 
Dress, % 63.2 63.5 63.4 63.2 0.23 0.96 0.06 
KPH fat, % 2.18 2.13 2.15 2.16 0.035 0.45 0.10 
12th rib fat 
thickness, cm 
1.52 1.57 1.57 1.55 0.04 0.70 0.40 
LM area, cm2 79.3 81.7 81.0 79.4 0.87 0.85 0.01 
Marbling score3 439 441 449 460 9.2 0.03 0.47 
Calculated YG4 3.47 3.40 3.45 3.50 0.057 0.50 0.25 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IH; Merck Animal Health) 
3 400 = small 00; 500 = modest 00; 600 = moderate 00 
4 Calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 [KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, 
cm2) (USDA, 2016) 
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Table 3.4. Effect of days on terminal implant on quality and yield grade distribution for 
heifers fed 181 d (Exp.1) 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant 
(Revalor-IH; Merck Animal Health) 
a, b Means without common superscripts differ (P ≤ 0.05) for quality grade distribution 
x, y Means without common superscripts differ (P ≤ 0.05) for yield grade distribution 
 
 
 
 
 
 
 
 
 
 Days on Terminal Implant
1   
 160
a, x 120b, x 80a, x 40a, y  P-Value 
Quality Grade, %      < 0.01 
Prime 1.8 2.0 2.2 3.9   
Choice 76.8 77.2 81.1 77.9   
Select 21.2 20.4 16.4 17.8   
No Roll 0.2 0.4 0.2 0.4   
Yield Grade, %     < 0.01  
1 4.9 5.4 4.5 3.0   
2 22.5 26.0 22.4 23.7   
3 47.4 41.7 48.2 43.8   
4 22.4 24.3 23.0 26.5   
5 2.8 2.6 1.9 3.0   
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Figure 3.1 Response curves and equations of varying days on terminal implant for heifers fed 181 d (Exp. 1).  
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Figure Description: Response to days on terminal implant in heifers that were initially implanted with Revalor-IH (80 mg TBA + 8 
mg estradiol; Merck Animal Health) and reimplanted with Revalor-200 (200 mg TBA + 20 mg estradiol) respective to treatment (160, 
120, 80, or 40 days on terminal implant). A quadratic response (P ≤ 0.04) was observed for carcass-adjusted final BW, ADG, G:F, 
HCW and LM area. When the first-derivative was solved, all variables were optimized between 88 and 103 DOT, with an average of 
94 DOT.  
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Table 3.5. Quadratic equations for response variables when heifers are fed for 181 d (Exp. 1) 
Response Variable Equation 
R2- 
Value 
Quadratic 
P-Value 
Carcass-Adj. BW y = -0.00167x2 (±0.001305) – 0.31x (±0.2650) + 532.75 (±11.6212) 0.0847 0.04 
Carcass-Adj. ADG y = -0.00001x2 (±0.0000608) – 0.002065x (±0.001235) + 1.5021 (±0.05414) 0.1295 0.01 
Carcass Adj. G:F y = 0.00000174x2 (±0.00498) – 0.000317x (±0.000133) +0.1700 (±0.005835) 0.3002 0.01 
LM Area y = -0.00063x2 (±0.000268) + 0.1272x (±0.05452) + 75.1992 (±2.3907) 0.2083 0.01 
HCW y = -0.00104x2 (±0.000829) – 0.1942x (±0.1685) + 339.67 (±7.3885) 0.0847 0.03 
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Table 3.6. Effect of days on terminal implant on growth performance of steers fed for 180 d (Exp. 2)  
 
 
Days on Terminal Implant1  P-Values 
 
160 120 100 80 40 SEM Trt2 Linear Quad 
Live Performance          
Initial Weight, kg 330 330 331 331 330 1.4 0.70 0.41 0.96 
Final Weight, kg3 657 667 672 667 659 4.8 0.17 0.32 0.05 
ADG, kg 1.83 1.89 1.90 1.89 1.83 0.025 0.11 0.42 0.03 
DMI, kg/d 11.8 11.9 11.8 11.7 11.4 0.09 0.01 0.18 0.93 
G:F 0.155 0.158 0.162 0.161 0.160 0.0018 0.04 0.90 0.01 
Carcass Adjusted Performance          
Final Weight, kg4 672 685 686 681 669 4.3 0.03 0.13 0.03 
ADG, kg5 1.91 1.98 1.98 1.97 1.89 0.022 0.01 0.18 0.02 
G:F5 0.161 0.166 0.169 0.168 0.165 0.0014 0.01 0.66 <0.01 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS; Merck Animal Health) 
2 F-test for effect of day on terminal implant 
3 Pencil shrunk 4% 
4 Carcass-adjusted performance calculated from HCW using a common dressing percentage of 63% 
106 
 
 
 
Table 3.7. Effect of days on terminal implant on interim growth performance of steers fed 
for 180 d (Exp 2)  
 Days on Terminal Implant
1 
    
 160 120 100 80 40 SEM F-Test Lin. Quad. 
Day 1-20          
DMI, kg/d 9.2 9.4 9.4 9.3 9.2 0.09 0.47 0.16 0.77 
ADG, kg 1.54 1.62 1.78 1.54 1.49 0.114 0.48 0.13 0.32 
G:F 0.168 0.172 0.189 0.167 0.162 0.0119 0.56 0.16 0.32 
Day 21-61 
       
  
DMI, kg/d 11.2 11.4 11.1 11.3 11.0 0.14 0.42 0.99 0.96 
ADG, kg 2.39 2.14 2.09 2.22 2.16 0.059 <0.01 0.12 0.09 
G:F 0.213 0.188 0.188 0.197 0.195 0.0054 0.01 0.17 0.12 
Day 62-81 
       
  
DMI, kg/d 12.6 12.1 12.3 12.4 11.9 0.15 0.04 0.92 0.35 
ADG, kg 2.38 2.52 2.31 2.29 2.25 0.095 0.34 0.44 0.36 
G:F 0.188 0.208 0.186 0.183 0.189 0.0077 0.16 0.43 0.17 
Day 82-101 
       
  
DMI, kg/d 12.3 12.4 11.4 11.8 12.0 0.17 <0.01 0.35 <0.01 
ADG, kg 1.67 1.89 1.78 1.58 1.47 0.100 0.06 0.03 0.95 
G:F 0.135 0.152 0.155 0.134 0.122 0.0076 0.02 <0.01 0.23 
Day 102-141 
       
  
DMI, kg/d 12.6 12.8 12.4 12.1 12.1 0.13 <0.01 0.01 0.12 
ADG, kg 1.78 2.01 2.04 1.97 1.79 0.054 <0.01 0.09 <0.01 
G:F 0.141 0.158 0.164 0.163 0.149 0.0039 <0.01 0.45 <0.01 
Day 142-180 
       
  
DMI, kg/d 12.3 12.7 12.8 12.7 11.8 0.17 <0.01 0.14 <0.01 
ADG, kg 1.22 1.23 1.45 1.52 1.65 0.082 <0.01 0.1 0.08 
G:F 0.099 0.097 0.114 0.121 0.139 0.0063 <0.01 0.03 0.25 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS; 
Merck Animal Health). Terminal implants were administered on d 21, 61, 101, 121, and 141.  
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Table 3.8. Effect of days on terminal implant on carcass characteristics of steers fed for 180 d (Exp 2)  
 Days on Terminal Implant1  P-Values 
 160 120 100 80 40 SEM Treatment Linear Quad 
HCW, kg 424 431 432 429 422 2.7 0.03 0.14 0.03 
LM area, cm2 88.4 90.3 91.6 89.0 89.7 0.52 <0.01 <0.01 0.09 
Fat Thickness, cm 1.65 1.63 1.63 1.63 1.60 0.038 0.81 0.66 0.97 
USDA marbling 3 517 530 541 534 534 7.5 0.27 0.60 0.11 
Calc. Yield 
Grade4 
3.79 3.72 3.69 3.77 3.64 0.060 0.38 0.52 0.89 
1 Days on terminal implant (Revalor-200; Merck Animal Health) after initial implant (Revalor-IS; Merck Animal Health) 
3 400 = small 00; 500 = modest 00; 600 = moderate 00 
4 Calculated using the following equation: Yield grade calculated using the following equation: 2.5 + (0.98425 x 12th rib fat, cm) + (0.2 x 3.0 
[KPH, %]) + (0.00837 x HCW, kg) – (0.0496 x LM area, cm2) 
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Figure 3.2 Quadratic response and equations of variables across days on terminal implant for steers fed for 180 d (Exp. 2) 
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Figure Description: Response to days on terminal implant in steers that were initially implanted with Revalor-IS (80 mg TBA + 16 
mg estradiol; Merck Animal Health) and reimplanted with Revalor-200 (200 mg TBA + 20 mg estradiol) respective to treatment. A 
quadratic response (P ≤ 0.03) was observed for carcass-adjusted final BW, ADG, G:F, and HCW. When solved for the first derivative, 
DOT was maximized at 104, 99, 87, and 104, respectively.  
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Table 3.9 Quadratic equations for response variables when steers are fed for 180 d (Exp. 2) 
 
Response Variable Equation 
R2- 
Value 
Quad P-
Value 
Carcass-Adj. BW y = -0.00401x2 (±0.001125) +0.8352 (±0.2596) + 701.80 (±11.7339) 0.0248 0.03 
Carcass-Adj. ADG y = -0.0001906x2 (±0.0009277) – 0.0037804 (±0.001894) + 1.7087 (±0.0880358) 0.1027 0.02 
Carcass Adj. G:F y = 0.00000128x2 (±0.000000577) – 0.00022x (±0.0001179) +0.1587 (±0.005479) 0.1581 <0.01 
HCW y = -0.00252x2 (±0.0.002664) – 0.5251x (±0.5438) + 405.70 (±11.4725) 0.0247 0.03 
 
